这是一篇来自已证抗体库的有关小鼠 Mapk1的综述,是根据482篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Mapk1 抗体。
Mapk1 同义词: 9030612K14Rik; AA407128; AU018647; C78273; ERK; Erk2; MAPK2; PRKM2; Prkm1; p41mapk; p42mapk

圣克鲁斯生物技术
小鼠 单克隆
  • 免疫印迹; 小鼠; 图 s3b
  • 免疫印迹; 人类; 图 s3b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在小鼠样本上 (图 s3b) 和 被用于免疫印迹在人类样本上 (图 s3b). Nature (2019) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:200; 图 4s2a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC7383)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 4s2a). elife (2019) ncbi
小鼠 单克隆(33)
  • 免疫沉淀; 人类; 图 3d
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136288)被用于被用于免疫沉淀在人类样本上 (图 3d) 和 被用于免疫印迹在人类样本上 (图 2b). Oncogenesis (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 s3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上 (图 s3a). Sci Adv (2019) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-135,900)被用于被用于免疫印迹在大鼠样本上 (图 3c). BMC Complement Altern Med (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:5000; 图 1c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1c). Nat Commun (2019) ncbi
小鼠 单克隆(12A4)
  • 免疫印迹; 人类; 图 3a
  • 免疫印迹; 小鼠; 图 2d
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-81457)被用于被用于免疫印迹在人类样本上 (图 3a) 和 被用于免疫印迹在小鼠样本上 (图 2d). Oncogene (2019) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 2e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上 (图 2e). Exp Mol Med (2018) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 3g, s7c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上 (图 3g, s7c). Cell (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 8a
圣克鲁斯生物技术 Mapk1抗体(santa cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 8a). J Exp Med (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 4d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology Inc, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 4d). J Clin Invest (2018) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Restor Neurol Neurosci (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Restor Neurol Neurosci (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4)被用于被用于免疫印迹在人类样本上 (图 2b). Cell Death Dis (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, E-4)被用于被用于免疫印迹在人类样本上 (图 5a). Cell Res (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 6d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology Inc, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 6d). Neurotherapeutics (2018) ncbi
小鼠 单克隆(12D4)
  • 免疫组化-冰冻切片; 小鼠; 1:20; 图 s6f
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-81492)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:20 (图 s6f). Nat Commun (2018) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 图 3b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上 (图 3b). Int J Oncol (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5). Mol Med Rep (2018) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). Oncotarget (2017) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 图 7a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上 (图 7a). Cancer Lett (2017) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 1:1000; 图 s7a
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-1647)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s7a). Nat Commun (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3g
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 3g). J Exp Med (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3e
圣克鲁斯生物技术 Mapk1抗体(SCB, E-4)被用于被用于免疫印迹在人类样本上 (图 3e). Cancer Res (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Oncol Lett (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 4b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 4b). J Exp Med (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). Exp Mol Med (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上 (图 6a). Exp Mol Med (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 图 6A
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上 (图 6A). Sci Rep (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 6
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 6). J Ethnopharmacol (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). Toxicol In Vitro (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:200; 图 2b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 2b). Toxicol In Vitro (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2b). J Steroid Biochem Mol Biol (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:2000; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4a). Exp Ther Med (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D-2)被用于被用于免疫印迹在人类样本上 (图 1a). Nucleic Acids Res (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2e). Nat Commun (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上 (图 1c). Mol Carcinog (2017) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D2)被用于被用于免疫印迹在人类样本上 (图 1a). J Biol Chem (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫组化-石蜡切片在小鼠样本上. Acta Histochem (2017) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1a). Int J Cancer (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5b). Int J Mol Med (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上 (图 3a). Int J Mol Sci (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, Sc-7383)被用于被用于免疫印迹在大鼠样本上 (图 6b). Physiol Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1500; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 4a). Oncol Lett (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1500; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 4a). Oncol Lett (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, SC-514302)被用于被用于免疫印迹在小鼠样本上 (图 3). Blood Cancer J (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 3). Blood Cancer J (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫组化-石蜡切片; 人类; 图 7a
  • 免疫印迹; 人类; 1:500; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫组化-石蜡切片在人类样本上 (图 7a) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 5a). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 表 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (表 1). J Neuroinflammation (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, 7383)被用于被用于免疫印迹在人类样本上 (图 6e). Am J Physiol Heart Circ Physiol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 4b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Mol Cell Biochem (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3a). J Cereb Blood Flow Metab (2017) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 7a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 7a). J Immunol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 4). Mol Ther Methods Clin Dev (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 人类; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上 (图 5). Cell Rep (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上 (图 1a). J Biol Chem (2016) ncbi
小鼠 单克隆(12A4)
  • 免疫沉淀; 大鼠; 图 5c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-81457)被用于被用于免疫沉淀在大鼠样本上 (图 5c). PLoS ONE (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 大鼠; 图 5c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-136521)被用于被用于免疫印迹在大鼠样本上 (图 5c). PLoS ONE (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Cell Death Dis (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3). Oncol Lett (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 2a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 2a). J Cell Biol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2a). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3h
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E4)被用于被用于免疫印迹在人类样本上 (图 3h). Genes Cancer (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上 (图 6b). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 5d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5d). Oncotarget (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:200; 图 6A
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 6A). Front Pharmacol (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 1:200; 图 6A
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 6A). Front Pharmacol (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000; 图 s4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4). Nat Commun (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc1647)被用于被用于免疫印迹在人类样本上 (图 5a). Oncotarget (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:500; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, 7383)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 5a). Int J Endocrinol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 7c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 7c). J Biol Chem (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc7383)被用于被用于免疫印迹在人类样本上 (图 4). BMC Complement Altern Med (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc1647)被用于被用于免疫印迹在人类样本上 (图 4). BMC Complement Altern Med (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 s2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在小鼠样本上 (图 s2). Sci Rep (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:500; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3). Oncoimmunology (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). J Immunol Res (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:200; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 5). Genes Cancer (2016) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 1:200; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 5). Genes Cancer (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5). BMC Cancer (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 小鼠; 1:50; 图 5
  • 免疫组化; 小鼠; 1:50; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫细胞化学在小鼠样本上浓度为1:50 (图 5) 和 被用于免疫组化在小鼠样本上浓度为1:50 (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3c). Oncotarget (2016) ncbi
小鼠 单克隆
  • 免疫印迹; 大鼠; 图 10a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫印迹在大鼠样本上 (图 10a). Int J Mol Med (2016) ncbi
小鼠 单克隆
  • 免疫组化; 小鼠; 1:500; 图 3d
  • 免疫印迹; 小鼠; 1:500; 图 3d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-514302)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 3d) 和 被用于免疫印迹在小鼠样本上浓度为1:500 (图 3d). J Neurosci (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 8
  • 免疫印迹; 小鼠; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4)被用于被用于免疫印迹在人类样本上 (图 8) 和 被用于免疫印迹在小鼠样本上 (图 5). J Exp Med (2016) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 大鼠; 1:500; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-81492)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 6). Exp Ther Med (2016) ncbi
小鼠 单克隆(C-8)
  • 免疫印迹; 小鼠; 图 8f
圣克鲁斯生物技术 Mapk1抗体(santa cruz, C-8)被用于被用于免疫印迹在小鼠样本上 (图 8f). Front Endocrinol (Lausanne) (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠; 1:1000; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(12D4)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 5
  • 免疫印迹; 小鼠; 1:1000; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 5) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Sci Rep (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 7e
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 7e). J Immunol (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 图 1d
  • 免疫组化; 小鼠; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc7383)被用于被用于免疫印迹在大鼠样本上 (图 1d) 和 被用于免疫组化在小鼠样本上 (图 7). J Cell Mol Med (2016) ncbi
小鼠 单克隆(E-4)
  • 酶联免疫吸附测定; 人类; 1:500; 图 10
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:500 (图 10). Oncotarget (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:500; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruze, sc-7383)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 6). PLoS ONE (2016) ncbi
小鼠 单克隆(12A4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc81457)被用于被用于免疫印迹在人类样本上 (图 2). Breast Cancer Res (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 3). Drug Des Devel Ther (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 1:2000; 图 s3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 s3). Clin Cancer Res (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 10
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 10). J Neuroinflammation (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 2
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 s7
  • 免疫印迹; 小鼠; 1:1000; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2), 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 s7) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Nat Commun (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5c
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5c). Mol Cells (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5a). Apoptosis (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 S3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 S3). Oncotarget (2016) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上 (图 3). Biomed Res Int (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 s3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 s3). J Immunol Res (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫细胞化学; 小鼠; 1:200; 图 2
  • 免疫印迹; 小鼠; 1:1000; 图 2
  • 免疫组化; 非洲爪蛙; 1:50; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D-2)被用于被用于免疫细胞化学在小鼠样本上浓度为1:200 (图 2), 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2) 和 被用于免疫组化在非洲爪蛙样本上浓度为1:50 (图 5). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 8
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上 (图 8). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6a). Oncogene (2016) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC7383)被用于被用于免疫印迹在人类样本上. Int J Cancer (2016) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:2000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上浓度为1:2000. Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 3c
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 3c). Oncogene (2016) ncbi
小鼠 单克隆(H-9)
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-271451)被用于被用于免疫印迹在人类样本上 (图 3a). Cancer Cell Int (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:8000; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-135900)被用于被用于免疫印迹在人类样本上浓度为1:8000 (图 7). Int J Mol Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 猪; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在猪样本上 (图 2). J Immunol (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在人类样本上 (图 6b). BMC Cancer (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上 (图 3). Cancer Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Cardiovasc Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Laboratories, SC7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 图 6b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在小鼠样本上 (图 6b). J Exp Med (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在大鼠样本上浓度为1:1000. Int J Neuropsychopharmacol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-自由浮动切片; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫组化-自由浮动切片在大鼠样本上. Free Radic Biol Med (2015) ncbi
小鼠 单克隆(33)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136288)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Med Rep (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2). J Biomed Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在小鼠样本上. Virol Sin (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa-Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6). PLoS Pathog (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在小鼠样本上. Neuropharmacology (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上. Neuropharmacology (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 图 4d
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上 (图 4d). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Cancer Res (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 小鼠; 图 s4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在小鼠样本上 (图 s4). Br J Cancer (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 s8
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 s8). Autophagy (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 7
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在人类样本上 (图 7). PLoS ONE (2015) ncbi
小鼠 单克隆(MK1)
  • 染色质免疫沉淀 ; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotech, sc-135900)被用于被用于染色质免疫沉淀 在人类样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Neuroscience (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-135900)被用于被用于免疫印迹在小鼠样本上. J Nutr Biochem (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-81492)被用于被用于免疫印迹在小鼠样本上. J Nutr Biochem (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在大鼠样本上 (图 5). Mar Drugs (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在人类样本上 (图 5). Br J Nutr (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:500; 图 4g
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 4g). J Cell Sci (2015) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-136521)被用于被用于免疫印迹在人类样本上 (图 6). Curr Mol Med (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在人类样本上. Cell Mol Life Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500. Cell Signal (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上 (图 1). Nucleic Acids Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 2
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 小鼠; 1:500; 图 4a
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4a). Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5f
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5f). Cell Commun Signal (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500; 图 4
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-7383)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4). Nat Commun (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 小鼠
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnologies, SC-7383)被用于被用于免疫细胞化学在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Endocrinology (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 s21
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-7383)被用于被用于免疫印迹在人类样本上 (图 s21). PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Ther Med (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上. Mutat Res (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫沉淀; 人类; 图 3
  • 免疫细胞化学; 人类; 图 3
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-1647)被用于被用于免疫沉淀在人类样本上 (图 3), 被用于免疫细胞化学在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 4). Cell Death Differ (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫沉淀; 人类; 图 3
  • 免疫印迹; 人类; 图 s9
圣克鲁斯生物技术 Mapk1抗体(santa Cruz, sc-7383)被用于被用于免疫沉淀在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 s9). Cell Death Differ (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Mol Cell Endocrinol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Leuk Lymphoma (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上. Leuk Lymphoma (2015) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-136521)被用于被用于免疫印迹在大鼠样本上浓度为1:200. PLoS ONE (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在大鼠样本上浓度为1:200. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E4)被用于被用于免疫印迹在人类样本上 (图 2). Cell Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2). Cell Cycle (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 2b
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 2b). Environ Health Perspect (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC7383)被用于被用于免疫印迹在小鼠样本上浓度为1:200. Mol Cell Biol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4)被用于被用于免疫印迹在人类样本上 (图 1). J Biol Chem (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Oncotarget (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫组化; 人类; 1:100
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫组化在人类样本上浓度为1:100. Cancer Lett (2015) ncbi
小鼠 单克隆(D-2)
  • 免疫细胞化学; 人类; 1:200
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-1647)被用于被用于免疫细胞化学在人类样本上浓度为1:200 和 被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(12D4)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-81492)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Life Sci (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Life Sci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在人类样本上浓度为1:1000. Tumour Biol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nat Neurosci (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 图 3
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在大鼠样本上 (图 3). Biochem Pharmacol (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Cell Res (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000. Exp Cell Res (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Oncotarget (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, 7383)被用于被用于免疫印迹在人类样本上 (图 1). Cell Cycle (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠; 1:500; 图 2
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 2). Nat Commun (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Biol Chem (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Biol Chem (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 大鼠
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, E-4, sc-7383)被用于被用于免疫组化-石蜡切片在大鼠样本上 和 被用于免疫印迹在大鼠样本上. Hippocampus (2015) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类; 1:800
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, SC-135900)被用于被用于免疫印迹在人类样本上浓度为1:800. Growth Factors (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; kangaroo rats; 1:200; 图 2
圣克鲁斯生物技术 Mapk1抗体(santa cruz, sc-7383)被用于被用于免疫印迹在kangaroo rats样本上浓度为1:200 (图 2). Cell Mol Neurobiol (2015) ncbi
小鼠 单克隆(12D4)
  • 免疫细胞化学; 人类; 1:300
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotech, sc-81492)被用于被用于免疫细胞化学在人类样本上浓度为1:300. Biores Open Access (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上. Biometals (2014) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-1647)被用于被用于免疫印迹在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-135900)被用于被用于免疫印迹在小鼠样本上. J Am Heart Assoc (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. J Virol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000. BMC Cancer (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫组化-石蜡切片; 人类; 1:100
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc7383)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. J Gastroenterol Hepatol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 牛
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在牛样本上. Biomed Res Int (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Angiogenesis (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在人类样本上. Int J Oncol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Int J Oncol (2014) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-1647)被用于被用于免疫印迹在人类样本上. Pigment Cell Melanoma Res (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; domestic rabbit; 1:1,000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在domestic rabbit样本上浓度为1:1,000. Stem Cells Dev (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. Mol Cell Endocrinol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000; 图 1
圣克鲁斯生物技术 Mapk1抗体(Santa, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Mol Cancer Ther (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在人类样本上. Biochem Pharmacol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc7383)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上. Electrophoresis (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在小鼠样本上. Exp Mol Med (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 番茄
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, SC-7383)被用于被用于免疫印迹在番茄样本上. J Agric Food Chem (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, E-4)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Cancer Res (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫细胞化学; 大鼠
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫细胞化学在大鼠样本上 和 被用于免疫印迹在大鼠样本上. Glia (2014) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(pT202/pY204.22A)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-136521)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Exp Cell Res (2014) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 大鼠; 1:200
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-135900)被用于被用于免疫印迹在大鼠样本上浓度为1:200. Exp Cell Res (2014) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, D2)被用于被用于免疫印迹在人类样本上. J Biol Chem (2013) ncbi
小鼠 单克隆(MK1)
  • 免疫印迹; 人类
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-135900)被用于被用于免疫印迹在人类样本上. Cancer Cell Int (2013) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Neurodegener (2012) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Neurodegener (2012) ncbi
小鼠 单克隆(D-2)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-1647)被用于被用于免疫印迹在人类样本上浓度为1:500. J Neuroimmunol (2013) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上浓度为1:500. J Neuroimmunol (2013) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz Biotechnology, sc-7383)被用于被用于免疫印迹在大鼠样本上. Lab Anim Res (2012) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 大鼠; 1:1000; 图 3b
圣克鲁斯生物技术 Mapk1抗体(SantaCruz, E-4)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3b). Am J Physiol Gastrointest Liver Physiol (2011) ncbi
小鼠 单克隆(E-4)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术 Mapk1抗体(Santa Cruz, sc-7383)被用于被用于免疫印迹在人类样本上 (图 5). Leukemia (2011) ncbi
赛默飞世尔
小鼠 单克隆(MILAN8R)
  • 流式细胞仪; 人类; 图 s5
赛默飞世尔 Mapk1抗体(eBioscience, MILAN8R)被用于被用于流式细胞仪在人类样本上 (图 s5). Eur J Immunol (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 4b
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, 44-654G)被用于被用于免疫印迹在大鼠样本上 (图 4b). Biosci Rep (2018) ncbi
小鼠 单克隆(MILAN8R)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔 Mapk1抗体(eBioscience, MILAN8R)被用于被用于流式细胞仪在人类样本上 (图 3b). J Immunol (2018) ncbi
小鼠 单克隆(3F8B3)
  • 免疫印迹; Stylophora pistillata; 1:1000; 图 2a
  • 免疫印迹; 人类; 图 4
赛默飞世尔 Mapk1抗体(ThermoFisher, MA5-15605)被用于被用于免疫印迹在Stylophora pistillata样本上浓度为1:1000 (图 2a) 和 被用于免疫印迹在人类样本上 (图 4). F1000Res (2017) ncbi
domestic rabbit 单克隆(B.742.5)
  • 免疫印迹; Stylophora pistillata; 1:1000; 图 2a
  • 免疫印迹; 人类; 图 4
赛默飞世尔 Mapk1抗体(ThermoFisher, MA5-15174)被用于被用于免疫印迹在Stylophora pistillata样本上浓度为1:1000 (图 2a) 和 被用于免疫印迹在人类样本上 (图 4). F1000Res (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫沉淀; 人类; 图 5a
  • 免疫印迹; 人类; 图 5a
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫沉淀在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上 (图 5a). Sci Rep (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 1:500; 图 3a
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3a). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1d
赛默飞世尔 Mapk1抗体(Invitrogen, 44-654G)被用于被用于免疫印迹在人类样本上 (图 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1d
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 5e
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上 (图 5e). MAbs (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3b
赛默飞世尔 Mapk1抗体(Invitrogen, 61-7400)被用于被用于免疫印迹在人类样本上 (图 3b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; African green monkey; 图 5c
赛默飞世尔 Mapk1抗体(Zymed, 61-7400)被用于被用于免疫印迹在African green monkey样本上 (图 5c). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1b
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1b). Int J Oncol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s3b
  • 免疫印迹; 小鼠; 图 5e
赛默飞世尔 Mapk1抗体(生活技术, 44-654G)被用于被用于免疫印迹在人类样本上 (图 s3b) 和 被用于免疫印迹在小鼠样本上 (图 5e). Nat Immunol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5e
  • 免疫印迹; 人类; 图 s3b
赛默飞世尔 Mapk1抗体(生活技术, 44-680G)被用于被用于免疫印迹在小鼠样本上 (图 5e) 和 被用于免疫印迹在人类样本上 (图 s3b). Nat Immunol (2016) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 1:2000; 图 2a
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, ERK-7D8)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3
赛默飞世尔 Mapk1抗体(生活技术, 44-654-G)被用于被用于免疫印迹在人类样本上 (图 3). Int J Mol Sci (2016) ncbi
小鼠 单克隆(MILAN8R)
  • 流式细胞仪; 小鼠
赛默飞世尔 Mapk1抗体(eBioscience, MILAN8R)被用于被用于流式细胞仪在小鼠样本上. Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4
赛默飞世尔 Mapk1抗体(Invitrogen, 44680G)被用于被用于免疫印迹在人类样本上 (图 4). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 图 3
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 44680G)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 1). BMC Cancer (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
赛默飞世尔 Mapk1抗体(Invitrogen Biosource, 44-654G)被用于被用于免疫印迹在人类样本上 (图 6). J Biol Chem (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:5000; 图 5
赛默飞世尔 Mapk1抗体(Zymed, 61-7400)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 5). Neuropharmacology (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 5
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在大鼠样本上 (图 5). Mol Biol Cell (2016) ncbi
domestic rabbit 多克隆
赛默飞世尔 Mapk1抗体(Thermo Fisher Scientific, 44-680G)被用于. Biomed Res Int (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 44-680G)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:500; 图 5b
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5b). Nat Cell Biol (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(K.913.4)
  • 免疫组化-石蜡切片; 斑马鱼
  • 免疫印迹; 斑马鱼
赛默飞世尔 Mapk1抗体(Pierce, MA5-15134)被用于被用于免疫组化-石蜡切片在斑马鱼样本上 和 被用于免疫印迹在斑马鱼样本上. Cell Res (2014) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类
赛默飞世尔 Mapk1抗体(Zymed Laboratories, 13-6200)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 1:2500; 表 1
赛默飞世尔 Mapk1抗体(Invitrogen, 136200)被用于被用于免疫印迹在大鼠样本上浓度为1:2500 (表 1). Amino Acids (2012) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在人类样本上. Biochim Biophys Acta (2011) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 1
赛默飞世尔 Mapk1抗体(Invitrogen, 13-6200)被用于被用于免疫印迹在人类样本上 (图 1). J Endocrinol Invest (2011) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 图 2a
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在小鼠样本上 (图 2a). Nat Immunol (2006) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 图 6
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在大鼠样本上 (图 6). Cardiovasc Res (2006) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 图 7
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在大鼠样本上 (图 7). J Biomed Sci (2005) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 1:5000; 图 2
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在大鼠样本上浓度为1:5000 (图 2). Life Sci (2005) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 图 5
赛默飞世尔 Mapk1抗体(Zymed, 13-6200,)被用于被用于免疫印迹在大鼠样本上 (图 5). J Biol Chem (2004) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 2
赛默飞世尔 Mapk1抗体(Zymed Laboratories, clone ERK-7D8)被用于被用于免疫印迹在人类样本上 (图 2). J Neurochem (2000) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在大鼠样本上. J Clin Invest (1999) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 图 1, 2
赛默飞世尔 Mapk1抗体(Zymed, 13-6200)被用于被用于免疫印迹在小鼠样本上 (图 1, 2). Neurochem Res (1998) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫沉淀; 小鼠
  • 免疫印迹; 小鼠
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫沉淀在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Proc Natl Acad Sci U S A (1998) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 非洲爪蛙; 1:1000; 图 1
赛默飞世尔 Mapk1抗体(Zymed, ERK-7D8)被用于被用于免疫印迹在非洲爪蛙样本上浓度为1:1000 (图 1). Science (1998) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 人类; 图 3
赛默飞世尔 Mapk1抗体(Zymed Laboratories, clone ERK-7D8)被用于被用于免疫印迹在人类样本上 (图 3). J Biol Chem (1997) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 5a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab115799)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Biosci Rep (2019) ncbi
domestic rabbit 单克隆(EPR18444)
  • 免疫印迹; 人类; 图 5b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab214036)被用于被用于免疫印迹在人类样本上 (图 5b). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab115799)被用于被用于免疫印迹在人类样本上 (图 5b). Eur Rev Med Pharmacol Sci (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a). Lab Invest (2019) ncbi
domestic rabbit 单克隆(EPR19401)
  • 免疫印迹; 大鼠; 1:1000; 图 5c
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab201015)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5c). Exp Ther Med (2017) ncbi
domestic rabbit 单克隆(E460)
  • 免疫印迹; 人类; 1:100; 图 5b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab32081)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 5b). Exp Ther Med (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:100; 图 5a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 5a). Exp Ther Med (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 大鼠; 1:1000; 图 4b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4b). Braz J Med Biol Res (2017) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:500; 图 3a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 3a). J Mol Neurosci (2017) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 人类; 1:200; 图 6d
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 6d). J Cell Sci (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 4a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab196883)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4a). Exp Ther Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, Ab17942)被用于被用于免疫印迹在大鼠样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 大鼠
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, Ab50011)被用于被用于免疫印迹在大鼠样本上. PLoS ONE (2016) ncbi
domestic rabbit 单克隆(E460)
  • 免疫组化-石蜡切片; 人类; 图 1c
  • 免疫印迹; 人类; 图 6f
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab32081)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1c) 和 被用于免疫印迹在人类样本上 (图 6f). Oncotarget (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab17942)被用于被用于免疫印迹在大鼠样本上 (图 4). Mol Brain (2016) ncbi
domestic rabbit 单克隆(EPR19401)
  • 免疫印迹; 大鼠; 图 4
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab201015)被用于被用于免疫印迹在大鼠样本上 (图 4). Mol Brain (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 鸡; 1:200; 图 2b
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab79853)被用于被用于免疫印迹在鸡样本上浓度为1:200 (图 2b). Biometals (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫细胞化学; 人类; 图 2
  • 免疫印迹; 人类; 图 5
艾博抗(上海)贸易有限公司 Mapk1抗体(AbCam, Ab50011)被用于被用于免疫细胞化学在人类样本上 (图 2) 和 被用于免疫印迹在人类样本上 (图 5). Cancer Biol Ther (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2
艾博抗(上海)贸易有限公司 Mapk1抗体(AbCam, Ab17942)被用于被用于免疫细胞化学在人类样本上 (图 2). Cancer Biol Ther (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Oncotarget (2016) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 1d
艾博抗(上海)贸易有限公司 Mapk1抗体(abcam, 50011)被用于被用于免疫印迹在人类样本上 (图 1d). Mar Drugs (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 人类; 图 1
艾博抗(上海)贸易有限公司 Mapk1抗体(abcam, ab50011)被用于被用于免疫组化在人类样本上 (图 1). Mol Cancer (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 6
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 6). Biomaterials (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 图 2a
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上 (图 2a). Med Oncol (2015) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化-石蜡切片; 斑马鱼; 1:300
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化-石蜡切片在斑马鱼样本上浓度为1:300. J Immunol (2015) ncbi
小鼠 单克隆(ERK-7D8)
  • 免疫印迹; 小鼠; 1:2000; 图 1d
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab54230)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 1d). J Biol Chem (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 大鼠; 1:200
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化在大鼠样本上浓度为1:200. J Surg Res (2014) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫印迹; 人类; 1:50-500
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫印迹在人类样本上浓度为1:50-500. Reprod Biol Endocrinol (2013) ncbi
小鼠 单克隆(MAPK-YT)
  • 免疫组化; 人类; 1:200
艾博抗(上海)贸易有限公司 Mapk1抗体(Abcam, ab50011)被用于被用于免疫组化在人类样本上浓度为1:200. PLoS ONE (2013) ncbi
BioLegend
小鼠 单克隆(6B8B69)
  • 流式细胞仪; 人类; 图 4c
  • 免疫印迹; 人类; 图 3d
BioLegend Mapk1抗体(BioLegend, 369506)被用于被用于流式细胞仪在人类样本上 (图 4c) 和 被用于免疫印迹在人类样本上 (图 3d). Cell (2019) ncbi
小鼠 单克隆(4B11B69)
  • 免疫印迹; 小鼠; 图 6c
BioLegend Mapk1抗体(BioLegend, 4B11B69)被用于被用于免疫印迹在小鼠样本上 (图 6c). J Clin Invest (2018) ncbi
小鼠 单克隆(4B11B69)
  • 流式细胞仪; 小鼠; 图 3b
BioLegend Mapk1抗体(Biolegend, 4B11B69)被用于被用于流式细胞仪在小鼠样本上 (图 3b). Front Immunol (2017) ncbi
亚诺法生技股份有限公司
domestic rabbit 单克隆(G15-B)
  • 免疫印迹; 人类
亚诺法生技股份有限公司 Mapk1抗体(Abnova, G15-B)被用于被用于免疫印迹在人类样本上. J Transl Med (2015) ncbi
GeneTex
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1b
GeneTex Mapk1抗体(GeneTex, GTX17942)被用于被用于免疫印迹在人类样本上 (图 1b). Int J Oncol (2016) ncbi
西格玛奥德里奇
domestic rabbit 多克隆
  • 免疫印迹; 人类; 表 4
西格玛奥德里奇 Mapk1抗体(Sigma, M0800)被用于被用于免疫印迹在人类样本上 (表 4). Transl Psychiatry (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1
  • 免疫印迹; 人类; 图 1
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M0800)被用于被用于免疫印迹在小鼠样本上 (图 1) 和 被用于免疫印迹在人类样本上 (图 1). Cell Div (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3
  • 免疫印迹; 人类; 图 3
西格玛奥德里奇 Mapk1抗体(Sigma, M0800)被用于被用于免疫印迹在小鼠样本上 (图 3) 和 被用于免疫印迹在人类样本上 (图 3). Oncogenesis (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 1
西格玛奥德里奇 Mapk1抗体(Sigma-Aldrich, M0800)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1). Biochem Pharmacol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:10,000; 图 s2b
西格玛奥德里奇 Mapk1抗体(Sigma, M0800)被用于被用于免疫印迹在大鼠样本上浓度为1:10,000 (图 s2b). Metallomics (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 5c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 197G2)被用于被用于免疫印迹在人类样本上 (图 5c). Breast Cancer Res (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 7a). elife (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3f
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3f). elife (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 s3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 s3e). J Clin Invest (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 e2b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 e2b). Nature (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 s1i
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 s1i). Cell (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:2000; 图 s2b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s2b). Nat Commun (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 7b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 7b). Cell (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 3d). Nature (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 大鼠; 1:2000; 图 2c
  • 免疫印迹; 大鼠; 1:1000; 图 s1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4376)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:2000 (图 2c) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (图 s1b). Histochem Cell Biol (2019) ncbi
  • 其他; 小鼠; 1:50; 图 3g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9926)被用于被用于其他在小鼠样本上浓度为1:50 (图 3g). Cell (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 6c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 6c). elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2000; 图 s4c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9108)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 s4c). Nat Commun (2019) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 5d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上 (图 5d). Cell Rep (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 人类; 图 5a
  • 免疫印迹; 人类; 图 6c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于流式细胞仪在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上 (图 6c). J Virol (2019) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫细胞化学; 人类; 1:1000; 图 s3c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 s3c). Genes Dev (2018) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 s17b
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s5j, s6h, s14f, s15g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 s17b) 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s5j, s6h, s14f, s15g). Nat Med (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2000; 图 2a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2a). J Neurochem (2018) ncbi
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, Inc, 9910s)被用于被用于免疫印迹在小鼠样本上 (图 4a). Front Pharmacol (2018) ncbi
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, Inc, 9926)被用于被用于免疫印迹在小鼠样本上 (图 4a). Front Pharmacol (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 小鼠; 图 9a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于流式细胞仪在小鼠样本上 (图 9a). J Exp Med (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 8b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8b). Br J Pharmacol (2018) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 6e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6e). Nat Commun (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 小鼠; 图 1c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于流式细胞仪在小鼠样本上 (图 1c). J Clin Invest (2018) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 3a). Brain Behav Immun (2018) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 9e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 9e). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3d). BMC Cancer (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 3e). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 小鼠; 1:400; 图 4f
  • 免疫印迹; 人类; 1:1000; 图 s4h
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化在小鼠样本上浓度为1:400 (图 4f) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 s4h). Nature (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:3000; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:3000 (图 3d). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4a). Breast Cancer (Dove Med Press) (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 7b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7b). Toxicol Appl Pharmacol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 9108)被用于被用于免疫印迹在人类样本上 (图 6b). elife (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上 (图 3). Front Aging Neurosci (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 3c
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在小鼠样本上 (图 3c) 和 被用于免疫印迹在人类样本上 (图 4a). Sci Signal (2017) ncbi
domestic rabbit 单克隆(197G2)
  • reverse phase protein lysate microarray; 人类; 图 st6
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4377)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1f
赛信通(上海)生物试剂有限公司 Mapk1抗体(cst, 4377S)被用于被用于免疫印迹在人类样本上 (图 1f). J Cell Sci (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 5a). Am J Respir Crit Care Med (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:5000; 图 1a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:5000 (图 1a). Cell Death Differ (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在人类样本上 (图 3a). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(197G2)
  • reverse phase protein lysate microarray; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 3a). Nature (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 人类; 1:200; 图 7b
  • 免疫印迹; 人类; 1:1000; 图 7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 7b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 7a). Nat Commun (2017) ncbi
  • 免疫印迹; 小鼠; 1:1000; 图 6a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9926)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Behav Brain Res (2017) ncbi
  • 免疫印迹; 小鼠; 1:1000; 图 6a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9910)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Behav Brain Res (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 s5f
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 s5f). Nature (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Cell Syst (2017) ncbi
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9910)被用于被用于免疫印迹在小鼠样本上. Atherosclerosis (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 6d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 9108)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6d). Sci Rep (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 12
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 12). J Neurosci Res (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 小鼠; 图 3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化在小鼠样本上 (图 3e). PLoS ONE (2016) ncbi
  • 免疫印迹; 大鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling technology, 9910)被用于被用于免疫印迹在大鼠样本上 (图 5). Oncotarget (2016) ncbi
  • 免疫印迹; 大鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling technology, 9926)被用于被用于免疫印迹在大鼠样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). Respir Res (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 2d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 2d). J Exp Med (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 6h
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 6h). Nature (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 4a). Int J Mol Sci (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上 (图 7a). Cell (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5a). Int J Mol Med (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3g
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3g). Oncogene (2017) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3h
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3h). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 其他; 人类; 1:50; 图 5e
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于其他在人类样本上浓度为1:50 (图 5e) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). BMC Cancer (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). J Physiol Biochem (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 2a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫印迹在小鼠样本上 (图 2a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s6c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6c). Nature (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化在小鼠样本上 (图 6). elife (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫印迹在小鼠样本上 (图 3a). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4377S)被用于被用于免疫印迹在人类样本上 (图 3e). Nature (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2000; 图 S11
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 S11). Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000; 图 s4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4). Nat Commun (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上 (图 2). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 6). Mol Hum Reprod (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 4a). elife (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 4b
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9108)被用于被用于免疫印迹在小鼠样本上 (图 4b) 和 被用于免疫印迹在人类样本上 (图 1b). Cell Signal (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 5c). Mucosal Immunol (2017) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Sci Rep (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 4376)被用于被用于免疫印迹在人类样本上 (图 5). Oncogenesis (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 20G11)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6). Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:500; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 6). Cell Death Differ (2016) ncbi
domestic rabbit 单克隆(D13.14.4E)
  • 免疫印迹; 小鼠; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 8544)被用于被用于免疫印迹在小鼠样本上 (图 5a). J Immunol (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signal, 4377S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s2). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 20G11)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Tech, 4377S)被用于被用于免疫印迹在人类样本上 (图 3). Sci Signal (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 s5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 s5). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 5e
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5e). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上. Sci Rep (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 5s3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5s3). elife (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377S)被用于被用于免疫印迹在人类样本上 (图 3d). J Exp Med (2016) ncbi
domestic rabbit 单克隆(197G2)
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 4377)被用于. Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:500; 图 1b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 1b). Nat Commun (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上 (图 5). Target Oncol (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s7). Brain Behav (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 6b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, cs4377s)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 6b). Development (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 人类; 图 2
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于流式细胞仪在人类样本上 (图 2) 和 被用于免疫印迹在人类样本上 (图 2). Oncogene (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Int J Mol Med (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 3). elife (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 1a). Oncotarget (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Tech, 4377)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3). Nat Neurosci (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:1000; 图 8
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 8). Sci Rep (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 5c). Sci Signal (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:150; 图 s3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:150 (图 s3). Mol Cancer (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 s5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 20G11)被用于被用于免疫印迹在小鼠样本上 (图 s5). Nature (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376S)被用于被用于免疫印迹在小鼠样本上 (图 3). Nat Struct Mol Biol (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376S)被用于被用于免疫印迹在大鼠样本上 (图 5). J Korean Med Sci (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 2,3,4,5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376s)被用于被用于免疫印迹在小鼠样本上 (图 2,3,4,5). Cell Res (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 6a, 6b
  • 免疫印迹; 人类; 图 3a, 4a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 6a, 6b) 和 被用于免疫印迹在人类样本上 (图 3a, 4a). Oncotarget (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500. Dev Biol (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 4d
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上 (图 4d). Oncotarget (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 s1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 s1). Mol Cancer Res (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2). elife (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 家羊; 1:2500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在家羊样本上浓度为1:2500. Mol Cell Endocrinol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 1). J Immunol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4377)被用于被用于免疫印迹在人类样本上. PLoS Pathog (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5). Oncogene (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 大鼠; 1:1000; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(cell signalling, 4376)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4). Toxicology (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 197G2)被用于被用于免疫印迹在小鼠样本上 (图 6). Mol Biol Cell (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 犬
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫组化-石蜡切片在犬样本上. Int J Oncol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上 (图 1). FASEB J (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000; 图 s3c
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies,, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s3c). Nat Commun (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1500; 图 st8
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 197G2)被用于被用于免疫印迹在人类样本上浓度为1:1500 (图 st8). Gastroenterology (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(CST, 20G11)被用于被用于免疫印迹在人类样本上. Acta Neuropathol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:500; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4). J Physiol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:500; 表 3
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:500 (表 3). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 图 s7a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4376)被用于被用于免疫印迹在小鼠样本上 (图 s7a). Nat Immunol (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling Technology, 4376)被用于被用于免疫组化-石蜡切片在人类样本上. Cancer Genet (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在人类样本上. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:2000; 图 5
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 197G2)被用于被用于免疫印迹在人类样本上. J Cell Mol Med (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1a
  • 免疫印迹; 小鼠; 图 1a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在人类样本上 (图 1a) 和 被用于免疫印迹在小鼠样本上 (图 1a). Mol Carcinog (2016) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上. Cell Signal (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 197G2)被用于被用于免疫印迹在人类样本上 (图 2). Oncotarget (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. PLoS ONE (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:1000; 图 7
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7). Mol Cell Biol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000; 图 s6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s6). Development (2015) ncbi
  • 免疫印迹; 小鼠; 图 6b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell signaling, 9910)被用于被用于免疫印迹在小鼠样本上 (图 6b). Cell Immunol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 8
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在小鼠样本上 (图 8). Mol Cell Biol (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在人类样本上浓度为1:1000. Am J Physiol Renal Physiol (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:25
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:25. PLoS Genet (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 20G11)被用于被用于免疫组化在人类样本上. Cancer Cell (2015) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 8a
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377S)被用于被用于免疫印迹在小鼠样本上 (图 8a). Free Radic Biol Med (2015) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 图 s4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s4). Nat Commun (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上. J Mol Endocrinol (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 20G11)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376S)被用于被用于免疫组化-石蜡切片在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Neoplasia (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 和 被用于免疫印迹在人类样本上浓度为1:1000. Int Immunopharmacol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling Technology, 4377S)被用于被用于免疫印迹在人类样本上 (图 1). Cell Prolif (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 猪; 1:500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在猪样本上浓度为1:500. Amino Acids (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上. Arthritis Rheumatol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Eur J Cancer (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:500. Free Radic Biol Med (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling technology, 4376)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 图 s1
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于免疫印迹在小鼠样本上 (图 s1). Nat Immunol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上. Cell Death Differ (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上. J Immunol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 大鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377S)被用于被用于免疫印迹在大鼠样本上. Brain Res (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:2500
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:2500. Brain Behav (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上. Breast Cancer Res (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在人类样本上浓度为1:1000. Int J Radiat Oncol Biol Phys (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-冰冻切片; 大鼠; 1:200
  • 免疫印迹; 大鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫组化-冰冻切片在大鼠样本上浓度为1:200 和 被用于免疫印迹在大鼠样本上浓度为1:1000. BMC Complement Altern Med (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 流式细胞仪; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 197G2)被用于被用于流式细胞仪在小鼠样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 小鼠; 1:75; 图 2
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:75 (图 2). Genes Dev (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377S)被用于被用于免疫印迹在人类样本上. Neuro Oncol (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 小鼠
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫组化-石蜡切片在小鼠样本上 和 被用于免疫印迹在小鼠样本上. J Biol Chem (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4377)被用于被用于免疫印迹在小鼠样本上. Am J Respir Cell Mol Biol (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 猪; 1:50
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signalling, 4376)被用于被用于免疫组化在猪样本上浓度为1:50. Dev Biol (2014) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫组化在人类样本上. Mol Cancer Ther (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nat Med (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4377)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:400
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 和 被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 小鼠; 1:200
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹在小鼠样本上浓度为1:200. Nat Med (2013) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologies, 4376)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:1000. Oncotarget (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technologie, 4377)被用于被用于免疫印迹在人类样本上. Oncogenesis (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4377)被用于被用于免疫印迹在人类样本上浓度为1:1000. Head Neck (2014) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫印迹在人类样本上. Cancer Cell Int (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠; 图 2b
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫组化在小鼠样本上 和 被用于免疫印迹在小鼠样本上 (图 2b). FASEB J (2013) ncbi
domestic rabbit 单克隆(197G2)
  • 免疫细胞化学; 小鼠; 图 4
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4377)被用于被用于免疫细胞化学在小鼠样本上 (图 4). Stem Cells (2012) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling, 4376)被用于被用于免疫印迹在人类样本上. J Appl Physiol (1985) (2012) ncbi
domestic rabbit 单克隆(20G11)
  • 免疫印迹基因敲除验证; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 Mapk1抗体(Cell Signaling Technology, 4376)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000. Development (2007) ncbi
默克密理博中国
domestic rabbit 重组(AW39R)
  • 免疫印迹; 大鼠; 1:1000; 图 5b
默克密理博中国 Mapk1抗体(Millipore, 05-797R)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5b). Vascul Pharmacol (2017) ncbi
小鼠 单克隆(1B3B9)
  • 免疫印迹; 人类; 图 5b,5c,6b,6c,6d
默克密理博中国 Mapk1抗体(Millipore, 05-157)被用于被用于免疫印迹在人类样本上 (图 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
domestic rabbit 重组(AW39R)
  • 免疫印迹; 人类
默克密理博中国 Mapk1抗体(Millipore, 05-797R)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2016) ncbi
domestic rabbit 重组(AW39R)
  • 免疫印迹; 小鼠; 图 1b
  • 免疫印迹; 人类; 图 1a
默克密理博中国 Mapk1抗体(Millipore, 05-797R)被用于被用于免疫印迹在小鼠样本上 (图 1b) 和 被用于免疫印迹在人类样本上 (图 1a). J Neuroinflammation (2016) ncbi
小鼠 单克隆(1B3B9)
  • 免疫印迹; 人类; 1:250; 图 2
默克密理博中国 Mapk1抗体(Millipore, 05-157)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 2). elife (2016) ncbi
小鼠 单克隆(1B3B9)
  • 免疫印迹; 人类; 图 s4d
默克密理博中国 Mapk1抗体(Millipore, 05-157)被用于被用于免疫印迹在人类样本上 (图 s4d). Oncotarget (2015) ncbi
domestic rabbit 重组(AW39R)
  • 免疫印迹; 大鼠; 1:1000; 图 2e
默克密理博中国 Mapk1抗体(Millipore, 05-797R)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2e). Front Behav Neurosci (2015) ncbi
小鼠 单克隆(1B3B9)
  • 免疫印迹; 小鼠; 图 1
默克密理博中国 Mapk1抗体(Millipore, 05-157)被用于被用于免疫印迹在小鼠样本上 (图 1). Nature (2015) ncbi
domestic rabbit 重组(AW39R)
  • 免疫印迹; 人类
默克密理博中国 Mapk1抗体(EMDMillipore, 05-797R)被用于被用于免疫印迹在人类样本上. Mol Cancer Ther (2015) ncbi
domestic rabbit 重组(AW39R)
  • 免疫细胞化学; 小鼠
默克密理博中国 Mapk1抗体(Millipore, 05-797R)被用于被用于免疫细胞化学在小鼠样本上. Glia (2015) ncbi
domestic rabbit 单克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6
默克密理博中国 Mapk1抗体(Millipore, 05-957)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). PLoS ONE (2012) ncbi
碧迪BD
小鼠 单克隆(33/ERK2)
  • 免疫印迹; 人类; 图 s6
碧迪BD Mapk1抗体(BD Biosciences, 610103)被用于被用于免疫印迹在人类样本上 (图 s6). Sci Rep (2016) ncbi
小鼠 单克隆(33/ERK2)
  • 免疫印迹; 人类
碧迪BD Mapk1抗体(BD Biosciences, 610104)被用于被用于免疫印迹在人类样本上. Biochem Biophys Res Commun (2014) ncbi
文章列表
  1. Lee Y, Ho S, Graves J, Xiao Y, Huang S, Lin W. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer. Breast Cancer Res. 2019;21:134 pubmed 出版商
  2. Sarek G, Kotsantis P, Ruis P, Van Ly D, Margalef P, Borel V, et al. CDK phosphorylation of TRF2 controls t-loop dynamics during the cell cycle. Nature. 2019;: pubmed 出版商
  3. Wang Q, Yang Q, Zhang A, Kang Z, Wang Y, Zhang Z. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep. 2019;39: pubmed 出版商
  4. Deng Q, Li P, Che M, Liu J, Biswas S, Ma G, et al. Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/β-Catenin. elife. 2019;8: pubmed 出版商
  5. Park M, Kim A, Manandhar S, Oh S, Jang G, Kang L, et al. CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity. elife. 2019;8: pubmed 出版商
  6. Sang D, Pinglay S, Wiewiora R, Selvan M, Lou H, Chodera J, et al. Ancestral reconstruction reveals mechanisms of ERK regulatory evolution. elife. 2019;8: pubmed 出版商
  7. Ligorio M, Sil S, Malagon Lopez J, Nieman L, Misale S, Di Pilato M, et al. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer. Cell. 2019;: pubmed 出版商
  8. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed 出版商
  9. Zhao J, Sun H, Zhang J, Wang M, Du X, Zhang J. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma. Eur Rev Med Pharmacol Sci. 2019;23:3173-3182 pubmed 出版商
  10. Jia Y, Li H, Wang J, Wang Y, Zhang P, Ma N, et al. Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis. Oncogenesis. 2019;8:31 pubmed 出版商
  11. Xu D, Li X, Shao F, Lv G, Lv H, Lee J, et al. The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62. Sci Adv. 2019;5:eaav4570 pubmed 出版商
  12. Shi Y, Gao W, Lytle N, Huang P, Yuan X, Dann A, et al. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Nature. 2019;569:131-135 pubmed 出版商
  13. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed 出版商
  14. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665 pubmed 出版商
  15. Hancock M, Meyer R, Mistry M, Khetani R, Wagschal A, Shin T, et al. Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression. Cell. 2019;177:722-736.e22 pubmed 出版商
  16. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed 出版商
  17. Mammone T, Chidlow G, Casson R, Wood J. Improved immunohistochemical detection of phosphorylated mitogen-activated protein kinases in the injured rat optic nerve head. Histochem Cell Biol. 2019;151:435-456 pubmed 出版商
  18. Joy M, Ben Assayag E, Shabashov Stone D, Liraz Zaltsman S, Mazzitelli J, Arenas M, et al. CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury. Cell. 2019;176:1143-1157.e13 pubmed 出版商
  19. Yambire K, Fernández Mosquera L, Steinfeld R, Mühle C, Ikonen E, Milosevic I, et al. Mitochondrial biogenesis is transcriptionally repressed in lysosomal lipid storage diseases. elife. 2019;8: pubmed 出版商
  20. Li J, Liu X, Chen H, Sun Z, Chen H, Wang L, et al. Multi-targeting chemoprevention of Chinese herb formula Yanghe Huayan decoction on experimentally induced mammary tumorigenesis. BMC Complement Altern Med. 2019;19:48 pubmed 出版商
  21. Dai L, Hu W, Yang Z, Chen D, He B, Chen Y, et al. Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis. Lab Invest. 2019;99:736-748 pubmed 出版商
  22. Jeong W, Park J, Kim W, Ro E, Jeon S, Lee S, et al. WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. Nat Commun. 2019;10:295 pubmed 出版商
  23. Smith B, Wang S, Jaime Figueroa S, Harbin A, Wang J, Hamman B, et al. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat Commun. 2019;10:131 pubmed 出版商
  24. Simula L, Pacella I, Colamatteo A, Procaccini C, Cancila V, Bordi M, et al. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming. Cell Rep. 2018;25:3059-3073.e10 pubmed 出版商
  25. Zhao H, Martin E, Matalkah F, Shah N, Ivanov A, Ruppert J, et al. Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis. Oncogene. 2019;38:2275-2290 pubmed 出版商
  26. Lee S, Cho Y, Cha P, Yoon J, Ro E, Jeong W, et al. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab. Exp Mol Med. 2018;50:153 pubmed 出版商
  27. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed 出版商
  28. Xu P, Chen A, Ganaie S, Cheng F, Shen W, Wang X, et al. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs. J Virol. 2019;93: pubmed 出版商
  29. McCloskey A, Ibarra A, Hetzer M. Tpr regulates the total number of nuclear pore complexes per cell nucleus. Genes Dev. 2018;32:1321-1331 pubmed 出版商
  30. Chen S, Yun F, Yao Y, Cao M, Zhang Y, Wang J, et al. USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein. J Exp Med. 2018;215:2850-2867 pubmed 出版商
  31. Imbrechts M, De Samblancx K, Fierens K, Brisse E, Vandenhaute J, Mitera T, et al. IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways. Eur J Immunol. 2018;48:1506-1521 pubmed 出版商
  32. Weiss J, Davies L, Karwan M, Ileva L, Ozaki M, Cheng R, et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J Clin Invest. 2018;128:3794-3805 pubmed 出版商
  33. Li F, Li Y, Liang H, Xu T, Kong Y, Huang M, et al. HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection. J Clin Invest. 2018;128:4148-4162 pubmed 出版商
  34. Li R, Sahu S, Schachner M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor Neurol Neurosci. 2018;36:469-483 pubmed 出版商
  35. Lei F, Jin L, Liu X, Lai F, Yan X, Farrelly M, et al. RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors. Cell Death Dis. 2018;9:679 pubmed 出版商
  36. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed 出版商
  37. Lautz J, Brown E, Williams VanSchoiack A, Smith S. Synaptic activity induces input-specific rearrangements in a targeted synaptic protein interaction network. J Neurochem. 2018;146:540-559 pubmed 出版商
  38. Xue Z, Vis D, Bruna A, Sustic T, van Wageningen S, Batra A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models. Cell Res. 2018;28:719-729 pubmed 出版商
  39. Huang M, Qi W, Fang S, Jiang P, Yang C, Mo Y, et al. Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42. Neurotherapeutics. 2018;15:728-741 pubmed 出版商
  40. Yu Y, Shen Q, Lai Y, Park S, Ou X, Lin D, et al. Anti-inflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol. 2018;9:386 pubmed 出版商
  41. Ahmad F, Salahuddin M, Alsamman K, Herzallah H, Al Otaibi S. Neonatal maternal deprivation impairs localized de novo activity-induced protein translation at the synapse in the rat hippocampus. Biosci Rep. 2018;38: pubmed 出版商
  42. Durai V, Bagadia P, Briseño C, Theisen D, Iwata A, Davidson J, et al. Altered compensatory cytokine signaling underlies the discrepancy between Flt3-/- and Flt3l-/- mice. J Exp Med. 2018;215:1417-1435 pubmed 出版商
  43. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  44. Lino Cardenas C, Kessinger C, Cheng Y, MacDonald C, Macgillivray T, Ghoshhajra B, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9:1009 pubmed 出版商
  45. Qi Z, Xu H, Zhang S, Xu J, Li S, Gao H, et al. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling. Int J Oncol. 2018;52:1105-1116 pubmed 出版商
  46. Lu Y, Kim N, Jiang Y, Zhang H, Zheng D, Zhu F, et al. Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function. Br J Pharmacol. 2018;175:1085-1099 pubmed 出版商
  47. Velázquez Villegas L, Perino A, Lemos V, Zietak M, Nomura M, Pols T, et al. TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue. Nat Commun. 2018;9:245 pubmed 出版商
  48. Qian Z, Ryu B, Kang K, Heo S, Kang D, Bae S, et al. Cellular properties of the fermented microalgae Pavlova lutheri and its isolated active peptide in osteoblastic differentiation of MG?63 cells. Mol Med Rep. 2018;17:2044-2050 pubmed 出版商
  49. Cho M, Lee J, Shin M, Kim H, Choi Y, Rho S, et al. TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer. Oncotarget. 2017;8:97990-98003 pubmed 出版商
  50. Wang C, Edilova M, Wagar L, Mujib S, Singer M, Bernard N, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200:558-564 pubmed 出版商
  51. Muro R, Nitta T, Nakano K, Okamura T, Takayanagi H, Suzuki H. γδTCR recruits the Syk/PI3K axis to drive proinflammatory differentiation program. J Clin Invest. 2018;128:415-426 pubmed 出版商
  52. Balan I, Warnock K, Puche A, GONDRE LEWIS M, Aurelian L. Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity. Brain Behav Immun. 2018;69:139-153 pubmed 出版商
  53. Liang Z, Yang Y, He Y, Yang P, Wang X, He G, et al. SUMOylation of IQGAP1 promotes the development of colorectal cancer. Cancer Lett. 2017;411:90-99 pubmed 出版商
  54. Tsutsumi R, Harizanova J, Stockert R, Schröder K, Bastiaens P, Neel B. Assay to visualize specific protein oxidation reveals spatio-temporal regulation of SHP2. Nat Commun. 2017;8:466 pubmed 出版商
  55. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed 出版商
  56. Quadri H, Aiken T, Allgaeuer M, Moravec R, Altekruse S, Hussain S, et al. Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer. BMC Cancer. 2017;17:495 pubmed 出版商
  57. Courtial L, Picco V, Pagès G, Ferrier Pagès C. Validation of commercial ERK antibodies against the ERK orthologue of the scleractinian coral Stylophora pistillata. F1000Res. 2017;6:577 pubmed 出版商
  58. Zhang C, Mao H, Cao Y. Nuclear accumulation of symplekin promotes cellular proliferation and dedifferentiation in an ERK1/2-dependent manner. Sci Rep. 2017;7:3769 pubmed 出版商
  59. Wang R, Cao X, Kulej K, Liu W, Ma T, MacDonald M, et al. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114:E5352-E5361 pubmed 出版商
  60. Kamerkar S, LeBleu V, Sugimoto H, Yang S, Ruivo C, Melo S, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498-503 pubmed 出版商
  61. Nishimura S, Mishra Gorur K, Park J, Surovtseva Y, Sebti S, Levchenko A, et al. Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc Natl Acad Sci U S A. 2017;114:5503-5508 pubmed 出版商
  62. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med. 2017;214:1471-1491 pubmed 出版商
  63. Chen M, Dai L, Fei A, Pan S, Wang H. Isoquercetin activates the ERK1/2-Nrf2 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Exp Ther Med. 2017;13:1353-1359 pubmed 出版商
  64. He L, Zhang L, Wang M, Wang W. miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway. Exp Ther Med. 2017;13:1203-1208 pubmed 出版商
  65. Yang X, Qi L, Lin F, Ou Z. The role of the chemokine receptor XCR1 in breast cancer cells. Breast Cancer (Dove Med Press). 2017;9:227-236 pubmed 出版商
  66. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed 出版商
  67. Yan X, Zhu Z, Xu S, Yang L, Liao X, Zheng M, et al. MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep. 2017;7:45915 pubmed 出版商
  68. Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, et al. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol. 2017;324:12-25 pubmed 出版商
  69. Mon N, Senga T, Ito S. Interleukin-1? activates focal adhesion kinase and Src to induce matrix metalloproteinase-9 production and invasion of MCF-7 breast cancer cells. Oncol Lett. 2017;13:955-960 pubmed 出版商
  70. Schweighoffer E, Nys J, Vanes L, Smithers N, Tybulewicz V. TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med. 2017;214:1269-1280 pubmed 出版商
  71. Fischer A, Harrison K, Ramirez Y, Auer D, Chowdhury S, Prusty B, et al. Chlamydia trachomatis-containing vacuole serves as deubiquitination platform to stabilize Mcl-1 and to interfere with host defense. elife. 2017;6: pubmed 出版商
  72. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed 出版商
  73. Yang K, Chen Y, To K, Wang F, Li D, Chen L, et al. Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo. Exp Mol Med. 2017;49:e303 pubmed 出版商
  74. Balmer D, Bapst Wicht L, Pyakurel A, Emery M, Nanchen N, Bochet C, et al. Bis-Retinoid A2E Induces an Increase of Basic Fibroblast Growth Factor via Inhibition of Extracellular Signal-Regulated Kinases 1/2 Pathway in Retinal Pigment Epithelium Cells and Facilitates Phagocytosis. Front Aging Neurosci. 2017;9:43 pubmed 出版商
  75. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed 出版商
  76. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  77. Li L, Baxter S, Gu N, Ji M, Zhan X. Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. J Cell Sci. 2017;130:1475-1485 pubmed 出版商
  78. Chung C, Chang C, Hsu C, Lin K, Peng H, Huang T. Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1. Sci Rep. 2017;7:43612 pubmed 出版商
  79. de Oliveira R, de Campos Castilho G, da Cunha A, Miyajima F, de Oliveira Martins D. Dilodendron bipinnatum Radlk. inhibits pro-inflammatory mediators through the induction of MKP-1 and the down-regulation of MAPKp38/JNK/NF-?B pathways and COX-2 in LPS-activated RAW 264.7 cells. J Ethnopharmacol. 2017;202:127-137 pubmed 出版商
  80. Pan X, Wang Y, Lübke T, Hinek A, Pshezhetsky A. Mice, double deficient in lysosomal serine carboxypeptidases Scpep1 and Cathepsin A develop the hyperproliferative vesicular corneal dystrophy and hypertrophic skin thickenings. PLoS ONE. 2017;12:e0172854 pubmed 出版商
  81. Wang H, Shan X, Qiao Y. PDK2 promotes chondrogenic differentiation of mesenchymal stem cells by upregulation of Sox6 and activation of JNK/MAPK/ERK pathway. Braz J Med Biol Res. 2017;50:e5988 pubmed 出版商
  82. Radder J, Zhang Y, Gregory A, Yu S, Kelly N, Leader J, et al. Extreme Trait Whole-Genome Sequencing Identifies PTPRO as a Novel Candidate Gene in Emphysema with Severe Airflow Obstruction. Am J Respir Crit Care Med. 2017;196:159-171 pubmed 出版商
  83. Tao C, Hsu W, Ma Y, Cheng S, Lee E. Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Aβ toxicity in a mouse model of Alzheimer's disease. Cell Death Differ. 2017;24:597-614 pubmed 出版商
  84. Ni Y, Teng T, Li R, Simonyi A, Sun G, Lee J. TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK. PLoS ONE. 2017;12:e0170346 pubmed 出版商
  85. Carpi S, Fogli S, Polini B, Montagnani V, Podestà A, Breschi M, et al. Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. Toxicol In Vitro. 2017;40:272-279 pubmed 出版商
  86. Difranco K, Mulligan J, Sumal A, Diamond G. Induction of CFTR gene expression by 1,25(OH)2 vitamin D3, 25OH vitamin D3, and vitamin D3 in cultured human airway epithelial cells and in mouse airways. J Steroid Biochem Mol Biol. 2017;173:323-332 pubmed 出版商
  87. Li M, Yuan Y, Hu B, Wu L. Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease. J Mol Neurosci. 2017;61:489-497 pubmed 出版商
  88. Lisse T, Rieger S. IKKα regulates human keratinocyte migration through surveillance of the redox environment. J Cell Sci. 2017;130:975-988 pubmed 出版商
  89. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed 出版商
  90. Schober T, Magg T, Laschinger M, Rohlfs M, Linhares N, Puchalka J, et al. A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun. 2017;8:14209 pubmed 出版商
  91. Feng L, Xue D, Chen E, Zhang W, Gao X, Yu J, et al. HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Exp Ther Med. 2016;12:3941-3947 pubmed 出版商
  92. Peng Y, Shi X, Li Z, He X, Sun Y. Particularly interesting Cys-His-rich protein is highly expressed in human intracranial aneurysms and resists aneurysmal rupture. Exp Ther Med. 2016;12:3905-3912 pubmed 出版商
  93. Asensio Juan E, Fueyo R, PAPPA S, Iacobucci S, Badosa C, Lois S, et al. The histone demethylase PHF8 is a molecular safeguard of the IFNγ response. Nucleic Acids Res. 2017;45:3800-3811 pubmed 出版商
  94. Xu X, Fan Z, Liang C, Li L, Wang L, Liang Y, et al. A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity. Nat Commun. 2017;8:14059 pubmed 出版商
  95. Su W, Zhang Y, Chen Y, Gong H, Lian Y, Peng W, et al. NLRP3 gene knockout blocks NF-?B and MAPK signaling pathway in CUMS-induced depression mouse model. Behav Brain Res. 2017;322:1-8 pubmed 出版商
  96. Babagana M, Johnson S, Slabodkin H, Bshara W, Morrison C, Kandel E. P21-activated kinase 1 regulates resistance to BRAF inhibition in human cancer cells. Mol Carcinog. 2017;56:1515-1525 pubmed 出版商
  97. Matsumoto A, Pasut A, Matsumoto M, Yamashita R, Fung J, Monteleone E, et al. mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 2017;541:228-232 pubmed 出版商
  98. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  99. Baumer Y, McCurdy S, Alcala M, Mehta N, Lee B, Ginsberg M, et al. CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis. Atherosclerosis. 2017;256:105-114 pubmed 出版商
  100. Takahashi M, Li Y, Dillon T, Stork P. Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP. J Biol Chem. 2017;292:1449-1461 pubmed 出版商
  101. Fourneaux B, Chaire V, Lucchesi C, Karanian M, Pineau R, Laroche Clary A, et al. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications. Oncotarget. 2017;8:7878-7890 pubmed 出版商
  102. Wang S, Cheng Y, Zheng Y, He Z, Chen W, Zhou W, et al. PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma. Sci Rep. 2016;6:39630 pubmed 出版商
  103. Lopes M, Leal R, Guarnieri R, Schwarzbold M, Hoeller A, Diaz A, et al. A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system. Transl Psychiatry. 2016;6:e986 pubmed 出版商
  104. Jung J, Jung H, Neupane S, Kim K, Kim J, Yamamoto H, et al. Involvement of PI3K and PKA pathways in mouse tongue epithelial differentiation. Acta Histochem. 2017;119:92-98 pubmed 出版商
  105. Nagahara Y, Shimazawa M, Ohuchi K, Ito J, Takahashi H, Tsuruma K, et al. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death. J Neurosci Res. 2017;95:1647-1665 pubmed 出版商
  106. Weyandt J, Carney J, Pavlisko E, Xu M, Counter C. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice. PLoS ONE. 2016;11:e0167205 pubmed 出版商
  107. Ferland D, Darios E, Neubig R, Sjögren B, Truong N, Torres R, et al. Chemerin-induced arterial contraction is Gi- and calcium-dependent. Vascul Pharmacol. 2017;88:30-41 pubmed 出版商
  108. Roversi F, Pericole F, Machado Neto J, da Silva Santos Duarte A, Longhini A, Corrocher F, et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochim Biophys Acta Mol Basis Dis. 2017;1863:450-461 pubmed 出版商
  109. Feng W, Zhang K, Liu Y, Chen J, Cai Q, Zhang Y, et al. Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2. Oncotarget. 2016;7:83588-83600 pubmed 出版商
  110. Wang Y, Chiang H, Huang Y, Hsu C, Yang P, Juan H, et al. A link between adipogenesis and innate immunity: RNase-L promotes 3T3-L1 adipogenesis by destabilizing Pref-1 mRNA. Cell Death Dis. 2016;7:e2458 pubmed 出版商
  111. Milara J, Cervera A, de Diego A, Sanz C, Juan G, Gavaldá A, et al. Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients. Respir Res. 2016;17:145 pubmed
  112. Hegedüs L, Garay T, Molnar E, Varga K, Bilecz A, Torok S, et al. The plasma membrane Ca2+ pump PMCA4b inhibits the migratory and metastatic activity of BRAF mutant melanoma cells. Int J Cancer. 2017;140:2758-2770 pubmed 出版商
  113. Hu Y, Kim J, He K, Wan Q, Kim J, Flach M, et al. Scramblase TMEM16F terminates T cell receptor signaling to restrict T cell exhaustion. J Exp Med. 2016;213:2759-2772 pubmed
  114. Grugan K, Dorn K, Jarantow S, Bushey B, Pardinas J, Laquerre S, et al. Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells. MAbs. 2017;9:114-126 pubmed 出版商
  115. Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed 出版商
  116. Li S, Yang B, Teguh D, Zhou L, Xu J, Rong L. Amyloid ? Peptide Enhances RANKL-Induced Osteoclast Activation through NF-?B, ERK, and Calcium Oscillation Signaling. Int J Mol Sci. 2016;17: pubmed
  117. Yue G, Xie S, Lee J, Kwok H, Gao S, Nian Y, et al. New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Sci Rep. 2016;6:35263 pubmed 出版商
  118. Rodina A, Wang T, Yan P, Gomes E, Dunphy M, Pillarsetty N, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538:397-401 pubmed 出版商
  119. Yong K, Li A, Ou W, Hong C, Zhao W, Wang F, et al. Targeting SALL4 by entinostat in lung cancer. Oncotarget. 2016;7:75425-75440 pubmed 出版商
  120. Belliard A, Gulati G, Duan Q, Alves R, Brewer S, Madan N, et al. Ischemia/reperfusion-induced alterations of enzymatic and signaling functions of the rat cardiac Na+/K+-ATPase: protection by ouabain preconditioning. Physiol Rep. 2016;4: pubmed
  121. Zhong W, Wang X, Pan B, Li F, Kuang L, Su Z. Eupatilin induces human renal cancer cell apoptosis via ROS-mediated MAPK and PI3K/AKT signaling pathways. Oncol Lett. 2016;12:2894-2899 pubmed
  122. Lu W, Shi J, Zhang J, Lv Z, Guo F, Huang H, et al. CXCL12/CXCR4 Axis Regulates Aggrecanase Activation and Cartilage Degradation in a Post-Traumatic Osteoarthritis Rat Model. Int J Mol Sci. 2016;17: pubmed
  123. Jin Q, Ren Y, Wang M, Suraneni P, Li D, Crispino J, et al. Novel function of FAXDC2 in megakaryopoiesis. Blood Cancer J. 2016;6:e478 pubmed 出版商
  124. Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, et al. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7:71400-71416 pubmed 出版商
  125. Xin H, ZHONG C, Nudleman E, Ferrara N. Evidence for Pro-angiogenic Functions of VEGF-Ax. Cell. 2016;167:275-284.e6 pubmed 出版商
  126. Jansson D, Scotter E, Rustenhoven J, Coppieters N, Smyth L, Oldfield R, et al. Interferon-? blocks signalling through PDGFR? in human brain pericytes. J Neuroinflammation. 2016;13:249 pubmed
  127. Egholm C, Khammy M, Dalsgaard T, Mazur A, Tritsaris K, Hansen A, et al. GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2016;311:H1214-H1224 pubmed 出版商
  128. Torres A, Vargas Y, Uribe D, Jaramillo C, Gleisner A, Salazar Onfray F, et al. Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells. Oncotarget. 2016;7:67373-67386 pubmed 出版商
  129. Zhong Y, Zou L, Wang Z, Pan Y, Dai Z, Liu X, et al. Lrrc75b is a novel negative regulator of C2C12 myogenic differentiation. Int J Mol Med. 2016;38:1411-1418 pubmed 出版商
  130. Yadav V, Hong K, Zeldin D, Nayeem M. Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels. Mol Cell Biochem. 2016;422:197-206 pubmed
  131. Gross S, Devraj K, Feng Y, Macas J, Liebner S, Wieland T. Nucleoside diphosphate kinase B regulates angiogenic responses in the endothelium via caveolae formation and c-Src-mediated caveolin-1 phosphorylation. J Cereb Blood Flow Metab. 2017;37:2471-2484 pubmed 出版商
  132. Wu Y, Ren D, Chen G. Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis. J Immunol. 2016;197:3336-3347 pubmed
  133. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed 出版商
  134. Wang H, Han X, Bretz C, Becker S, Gambhir D, Smith G, et al. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev. 2016;3:16056 pubmed 出版商
  135. García Carpizo V, Sarmentero J, Han B, Grana O, Ruiz Llorente S, Pisano D, et al. NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation. Sci Rep. 2016;6:32952 pubmed 出版商
  136. Makita N, Sato T, Yajima Shoji Y, Sato J, Manaka K, Eda Hashimoto M, et al. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist. J Biol Chem. 2016;291:22460-22471 pubmed
  137. Caporali S, Alvino E, Lacal P, Levati L, Giurato G, Memoli D, et al. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor. Int J Oncol. 2016;49:1164-74 pubmed 出版商
  138. Nettersheim D, Jostes S, Fabry M, Honecker F, Schumacher V, Kirfel J, et al. A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment. Oncotarget. 2016;7:74931-74946 pubmed 出版商
  139. Shang W, Zhao L, Dong X, Zhao Z, Li J, Zhang B, et al. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways. Mol Med Rep. 2016;14:3620-6 pubmed 出版商
  140. Padhan N, Nordling T, Sundstrom M, Akerud P, Birgisson H, Nygren P, et al. High sensitivity isoelectric focusing to establish a signaling biomarker for the diagnosis of human colorectal cancer. BMC Cancer. 2016;16:683 pubmed 出版商
  141. Kupka S, De Miguel D, Dráber P, Martino L, Surinova S, Rittinger K, et al. SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. Cell Rep. 2016;16:2271-80 pubmed 出版商
  142. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed 出版商
  143. Nehra S, Bhardwaj V, Bansal A, Saraswat D. Nanocurcumin accords protection against acute hypobaric hypoxia induced lung injury in rats. J Physiol Biochem. 2016;72:763-779 pubmed
  144. Li Y, Dillon T, Takahashi M, Earley K, Stork P. Protein Kinase A-independent Ras Protein Activation Cooperates with Rap1 Protein to Mediate Activation of the Extracellular Signal-regulated Kinases (ERK) by cAMP. J Biol Chem. 2016;291:21584-21595 pubmed
  145. Ruess D, Probst M, Marjanovic G, Wittel U, Hopt U, Keck T, et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS ONE. 2016;11:e0161233 pubmed 出版商
  146. Stucky A, Bakshi K, Friedman E, Wang H. Prenatal Cocaine Exposure Upregulates BDNF-TrkB Signaling. PLoS ONE. 2016;11:e0160585 pubmed 出版商
  147. Lagares Tena L, García Monclús S, López Alemany R, Almacellas Rabaiget O, Huertas Martínez J, Sáinz Jaspeado M, et al. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway. Oncotarget. 2016;7:56889-56903 pubmed 出版商
  148. Jiang Q, Chen S, Hu C, Huang P, Shen H, Zhao W. Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's disease. Mol Med Rep. 2016;14:2614-24 pubmed 出版商
  149. Di Siena S, Gimmelli R, Nori S, Barbagallo F, Campolo F, Dolci S, et al. Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury. Cell Death Dis. 2016;7:e2317 pubmed 出版商
  150. Ho J, Hsu R, Wu C, Liao G, Gao H, Wang T, et al. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2. Oncotarget. 2016;7:53853-53868 pubmed 出版商
  151. Shi K, Qian J, Qi L, Mao D, Chen Y, Zhu Y, et al. Atorvastatin antagonizes the visfatin-induced expression of inflammatory mediators via the upregulation of NF-?B activation in HCAECs. Oncol Lett. 2016;12:1438-1444 pubmed
  152. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed 出版商
  153. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  154. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed 出版商
  155. Inda C, Dos Santos Claro P, Bonfiglio J, Senin S, Maccarrone G, Turck C, et al. Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling. J Cell Biol. 2016;214:181-95 pubmed 出版商
  156. Fresco V, Kern C, Mohammadi M, Twal W. Fibulin-1 Binds to Fibroblast Growth Factor 8 with High Affinity: EFFECTS ON EMBRYO SURVIVAL. J Biol Chem. 2016;291:18730-9 pubmed 出版商
  157. Köchl R, Thelen F, Vanes L, Brazão T, Fountain K, Xie J, et al. WNK1 kinase balances T cell adhesion versus migration in vivo. Nat Immunol. 2016;17:1075-83 pubmed 出版商
  158. Wang C, Guo S, Wang J, Yan X, Farrelly M, Zhang Y, et al. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. Oncotarget. 2016;7:49597-49610 pubmed 出版商
  159. Elzi D, Song M, Blackman B, Weintraub S, Lopez Terrada D, Chen Y, et al. FGF19 functions as autocrine growth factor for hepatoblastoma. Genes Cancer. 2016;7:125-35 pubmed 出版商
  160. Chen Y, LaMarche M, Chan H, Fekkes P, García Fortanet J, Acker M, et al. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature. 2016;535:148-52 pubmed
  161. Madureira P, Bharadwaj A, Bydoun M, Garant K, O Connell P, Lee P, et al. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget. 2016;7:47720-47737 pubmed 出版商
  162. Zhao Y, Li Y, Luo P, Gao Y, Yang J, Lao K, et al. XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles. Sci Rep. 2016;6:28627 pubmed 出版商
  163. Aguilera O, Muñoz Sagastibelza M, Torrejón B, Borrero Palacios A, del Puerto Nevado L, Martínez Useros J, et al. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer. Oncotarget. 2016;7:47954-47965 pubmed 出版商
  164. Gautheron J, Vucur M, Schneider A, Severi I, Roderburg C, Roy S, et al. The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. Nat Commun. 2016;7:11869 pubmed 出版商
  165. Tisza M, Zhao W, Fuentes J, Prijic S, Chen X, Levental I, et al. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts. Oncotarget. 2016;7:51553-51568 pubmed 出版商
  166. Maugeri G, D Amico A, Reitano R, Magro G, Cavallaro S, Salomone S, et al. PACAP and VIP Inhibit the Invasiveness of Glioblastoma Cells Exposed to Hypoxia through the Regulation of HIFs and EGFR Expression. Front Pharmacol. 2016;7:139 pubmed 出版商
  167. Zhai W, Chen D, Shen H, Chen Z, Li H, Yu Z, et al. A1 adenosine receptor attenuates intracerebral hemorrhage-induced secondary brain injury in rats by activating the P38-MAPKAP2-Hsp27 pathway. Mol Brain. 2016;9:66 pubmed 出版商
  168. Hey F, Giblett S, Forrest S, Herbert C, Pritchard C. Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine. PLoS ONE. 2016;11:e0156877 pubmed 出版商
  169. Wang J, Farris A, Xu K, Wang P, Zhang X, Duong D, et al. GPRC5A suppresses protein synthesis at the endoplasmic reticulum to prevent radiation-induced lung tumorigenesis. Nat Commun. 2016;7:11795 pubmed 出版商
  170. Yu H. Sphingosine-1-Phosphate Receptor 2 Regulates Proinflammatory Cytokine Production and Osteoclastogenesis. PLoS ONE. 2016;11:e0156303 pubmed 出版商
  171. Blee A, Liu S, Wang L, Huang H. BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion. Oncotarget. 2016;7:38319-38332 pubmed 出版商
  172. Hanson R, Brown R, Steele M, Grandgenett P, Grunkemeyer J, Hollingsworth M. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget. 2016;7:39996-40011 pubmed 出版商
  173. Yang Z, Jiang Q, Chen S, Hu C, Shen H, Huang P, et al. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model. Mol Med Rep. 2016;14:790-6 pubmed 出版商
  174. Zhang C, Li L, Zhao B, Jiao A, Li X, Sun N, et al. Ghrelin Protects against Dexamethasone-Induced INS-1 Cell Apoptosis via ERK and p38MAPK Signaling. Int J Endocrinol. 2016;2016:4513051 pubmed 出版商
  175. Hudson C, McArdle C, López Bernal A. Steroid receptor co-activator interacting protein (SIP) mediates EGF-stimulated expression of the prostaglandin synthase COX2 and prostaglandin release in human myometrium. Mol Hum Reprod. 2016;22:512-25 pubmed 出版商
  176. Wu Y, Lan C, Ren D, Chen G. Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-?1 Production. J Biol Chem. 2016;291:12370-82 pubmed 出版商
  177. Choi H, Kim M, Choi Y, Shin Y, Cho S, Ko S. Rhus verniciflua Stokes (RVS) and butein induce apoptosis of paclitaxel-resistant SKOV-3/PAX ovarian cancer cells through inhibition of AKT phosphorylation. BMC Complement Altern Med. 2016;16:122 pubmed 出版商
  178. Kim S, Choi K, Cho S, Yun S, Jeon J, Koh Y, et al. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Sci Rep. 2016;6:24933 pubmed 出版商
  179. Willmer T, Hare S, Peres J, Prince S. The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cell Div. 2016;11:6 pubmed 出版商
  180. Yu Z, Chen T, Li X, Yang M, Tang S, Zhu X, et al. Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response. elife. 2016;5: pubmed 出版商
  181. Macritchie N, Volpert G, Al Washih M, Watson D, Futerman A, Kennedy S, et al. Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension. Cell Signal. 2016;28:946-55 pubmed 出版商
  182. Maselli A, Capoccia S, Pugliese P, Raggi C, Cirulli F, Fabi A, et al. Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation. Oncoimmunology. 2016;5:e1074375 pubmed
  183. Damle S, Martin R, Cross J, Conrad D. Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis. Mucosal Immunol. 2017;10:205-214 pubmed 出版商
  184. Shi C, Iura A, Terajima M, Liu F, Lyons K, Pan H, et al. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors. Sci Rep. 2016;6:24256 pubmed 出版商
  185. Papadakis E, Barker C, Syed H, Reeves T, Schwaiger S, Stuppner H, et al. The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ. Oncogenesis. 2016;5:e215 pubmed 出版商
  186. Alemán O, Mora N, Cortés Vieyra R, Uribe Querol E, Rosales C. Differential Use of Human Neutrophil Fc? Receptors for Inducing Neutrophil Extracellular Trap Formation. J Immunol Res. 2016;2016:2908034 pubmed 出版商
  187. Maugeri G, D Amico A, Rasà D, Reitano R, Saccone S, Federico C, et al. Expression profile of Wilms Tumor 1 (WT1) isoforms in undifferentiated and all-trans retinoic acid differentiated neuroblastoma cells. Genes Cancer. 2016;7:47-58 pubmed
  188. Huang J, Yao C, Chuang S, Yeh C, Lee L, Chen R, et al. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer. 2016;16:245 pubmed 出版商
  189. Margaryan N, Gilgur A, Seftor E, Purnell C, Arva N, Gosain A, et al. Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi. Int J Mol Sci. 2016;17:418 pubmed 出版商
  190. Yang Y, Xu J, Chen H, Fei X, Tang Y, Yan Y, et al. MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget. 2016;7:17520-31 pubmed 出版商
  191. Relic B, Charlier E, Deroyer C, Malaise O, Neuville S, Desoroux A, et al. BAY 11-7085 induces glucocorticoid receptor activation and autophagy that collaborate with apoptosis to induce human synovial fibroblast cell death. Oncotarget. 2016;7:23370-82 pubmed 出版商
  192. Lee J, Kim H, Rho S, Lee S. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells. Oncotarget. 2016;7:18541-57 pubmed 出版商
  193. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed 出版商
  194. Obino D, Farina F, Malbec O, Sáez P, Maurin M, Gaillard J, et al. Actin nucleation at the centrosome controls lymphocyte polarity. Nat Commun. 2016;7:10969 pubmed 出版商
  195. Acharya M, Sokolovska A, Tam J, Conway K, Stefani C, Raso F, et al. αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun. 2016;7:10917 pubmed 出版商
  196. Yang H, Vainshtein A, Maik Rachline G, Peles E. G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination. Nat Commun. 2016;7:10884 pubmed 出版商
  197. Atiq R, Hertz R, Eldad S, Smeir E, Bar Tana J. Suppression of B-Raf(V600E) cancers by MAPK hyper-activation. Oncotarget. 2016;7:18694-704 pubmed 出版商
  198. Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed 出版商
  199. Naik E, Dixit V. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity. J Immunol. 2016;196:3438-51 pubmed 出版商
  200. Yang W, Yang Y, Yang J, Liang M, Song J. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37:1075-82 pubmed 出版商
  201. Woo J, Srikanth S, Nishi M, Ping P, Takeshima H, Gwack Y. Junctophilin-4, a component of the endoplasmic reticulum-plasma membrane junctions, regulates Ca2+ dynamics in T cells. Proc Natl Acad Sci U S A. 2016;113:2762-7 pubmed 出版商
  202. Eriksson J, Le Joncour V, Nummela P, Jahkola T, Virolainen S, Laakkonen P, et al. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression. Oncotarget. 2016;7:15065-92 pubmed 出版商
  203. Abdul Rahman N, Greenwood S, Brett R, Tossell K, Ungless M, Plevin R, et al. Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory. J Neurosci. 2016;36:2348-54 pubmed 出版商
  204. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed 出版商
  205. Willmer T, Cooper A, Sims D, Govender D, Prince S. The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes. Oncogenesis. 2016;5:e199 pubmed 出版商
  206. Huo L, Shi W, Chong L, Wang J, Zhang K, Li Y. Asiatic acid inhibits left ventricular remodeling and improves cardiac function in a rat model of myocardial infarction. Exp Ther Med. 2016;11:57-64 pubmed
  207. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed 出版商
  208. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed 出版商
  209. Waters A, Stewart J, Atigadda V, Mroczek Musulman E, Muccio D, Grubbs C, et al. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies. Mol Cancer Ther. 2016;15:911-21 pubmed 出版商
  210. Krause C, Popp O, Thirunarayanan N, Dittmar G, Lipp M, Müller G. MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR. Oncotarget. 2016;7:10414-32 pubmed 出版商
  211. Ebbing E, Medema J, Damhofer H, Meijer S, Krishnadath K, van Berge Henegouwen M, et al. ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. Oncotarget. 2016;7:10243-54 pubmed 出版商
  212. Li S, Lu L, Liao X, Gao T, Wang F, Zhang L, et al. Manganese elevates manganese superoxide dismutase protein level through protein kinase C and protein tyrosine kinase. Biometals. 2016;29:265-74 pubmed 出版商
  213. O Sullivan C, Schubart A, Mir A, Dev K. The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures. J Neuroinflammation. 2016;13:31 pubmed 出版商
  214. Däbritz J, Judd L, Chalinor H, Menheniott T, Giraud A. Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep. 2016;6:20584 pubmed 出版商
  215. Coke C, Scarlett K, Chetram M, Jones K, Sandifer B, Davis A, et al. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression. J Biol Chem. 2016;291:9991-10005 pubmed 出版商
  216. Martin B, Chadwick W, Janssens J, Premont R, Schmalzigaug R, Becker K, et al. GIT2 Acts as a Systems-Level Coordinator of Neurometabolic Activity and Pathophysiological Aging. Front Endocrinol (Lausanne). 2015;6:191 pubmed 出版商
  217. Liu L, Zhu J, Zhou L, Wan L. RACK1 promotes maintenance of morphine-associated memory via activation of an ERK-CREB dependent pathway in hippocampus. Sci Rep. 2016;6:20183 pubmed 出版商
  218. Dorris E, Blackshields G, Sommerville G, Alhashemi M, Dias A, McEneaney V, et al. Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines. Cancer Biol Ther. 2016;17:526-42 pubmed 出版商
  219. Theodosiou M, Widmaier M, Böttcher R, Rognoni E, Veelders M, Bharadwaj M, et al. Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin. elife. 2016;5:e10130 pubmed 出版商
  220. Koyani C, Kitz K, Rossmann C, Bernhart E, Huber E, Trummer C, et al. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death. Biochem Pharmacol. 2016;104:29-41 pubmed 出版商
  221. Hattermann K, Gebhardt H, Krossa S, Ludwig A, Lucius R, Held Feindt J, et al. Transmembrane chemokines act as receptors in a novel mechanism termed inverse signaling. elife. 2016;5:e10820 pubmed 出版商
  222. Peres T, Ong L, Costa A, Eyng H, Venske D, Colle D, et al. Tyrosine hydroxylase regulation in adult rat striatum following short-term neonatal exposure to manganese. Metallomics. 2016;8:597-604 pubmed 出版商
  223. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed 出版商
  224. Chan A, Punwani D, Kadlecek T, Cowan M, Olson J, Mathes E, et al. A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med. 2016;213:155-65 pubmed 出版商
  225. Lv P, Tong X, Peng Q, Liu Y, Jin H, Liu R, et al. Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes. Mol Med Rep. 2016;13:2007-16 pubmed 出版商
  226. Chen Y, Zheng Y, You X, Yu M, Fu G, Su X, et al. Kras Is Critical for B Cell Lymphopoiesis. J Immunol. 2016;196:1678-85 pubmed 出版商
  227. Peng K, Tian X, Qian Y, Skibba M, Zou C, Liu Z, et al. Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II. J Cell Mol Med. 2016;20:482-94 pubmed 出版商
  228. Daniele S, Barresi E, Zappelli E, Marinelli L, Novellino E, Da Settimo F, et al. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells. Oncotarget. 2016;7:7866-84 pubmed 出版商
  229. Pivonello C, Negri M, De Martino M, Napolitano M, De Angelis C, Provvisiero D, et al. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma. Oncotarget. 2016;7:9718-31 pubmed 出版商
  230. Lin C, Wang C, Hsu S, Liao L, Lin T, Hsueh C. Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain. PLoS ONE. 2016;11:e0146692 pubmed 出版商
  231. Matalkah F, Martin E, Zhao H, Agazie Y. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer. Breast Cancer Res. 2016;18:2 pubmed 出版商
  232. Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun. 2016;7:10060 pubmed 出版商
  233. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed 出版商
  234. Hernandez R, Puro A, Manos J, Huitron Resendiz S, Reyes K, Liu K, et al. Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function. Neuropharmacology. 2016;103:27-43 pubmed 出版商
  235. Fan S, Numata Y, Numata M. Endosomal Na+/H+ exchanger NHE5 influences MET recycling and cell migration. Mol Biol Cell. 2016;27:702-15 pubmed 出版商
  236. Sun J, Fu X, Liu Y, Wang Y, Huo B, Guo Y, et al. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice. Drug Des Devel Ther. 2015;9:6327-42 pubmed 出版商
  237. Drilon A, Somwar R, Wagner J, Vellore N, Eide C, Zabriskie M, et al. A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer. Clin Cancer Res. 2016;22:2351-8 pubmed 出版商
  238. Huguet F, Fernet M, Giocanti N, Favaudon V, Larsen A. Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status. Target Oncol. 2016;11:371-81 pubmed 出版商
  239. Franco Villanueva A, Wandosell F, Antón I. Neuritic complexity of hippocampal neurons depends on WIP-mediated mTORC1 and Abl family kinases activities. Brain Behav. 2015;5:e00359 pubmed 出版商
  240. Audette D, Anand D, So T, Rubenstein T, Lachke S, Lovicu F, et al. Prox1 and fibroblast growth factor receptors form a novel regulatory loop controlling lens fiber differentiation and gene expression. Development. 2016;143:318-28 pubmed 出版商
  241. Daniele S, Zappelli E, Martini C. Trazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes. J Neuroinflammation. 2015;12:225 pubmed 出版商
  242. Duchnowska R, Wysocki P, Korski K, Czartoryska ArÅ‚ukowicz B, NiwiÅ„ska A, Orlikowska M, et al. Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients. Oncotarget. 2016;7:550-64 pubmed 出版商
  243. Bunda S, Burrell K, Heir P, Zeng L, Alamsahebpour A, Kano Y, et al. Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis. Nat Commun. 2015;6:8859 pubmed 出版商
  244. Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N, et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91 pubmed 出版商
  245. Lim J, Nguyen K, Han J, Jang I, Fabian C, Cho K. Direct Regulation of TLR5 Expression by Caveolin-1. Mol Cells. 2015;38:1111-7 pubmed 出版商
  246. Giri K, Pabelick C, Mukherjee P, Prakash Y. Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells. Apoptosis. 2016;21:329-39 pubmed 出版商
  247. Wang Z, Ma B, Li H, Xiao X, Zhou W, Liu F, et al. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC. Oncotarget. 2016;7:509-23 pubmed 出版商
  248. Ampofo E, Später T, Müller I, Eichler H, Menger M, Laschke M. The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity. Mar Drugs. 2015;13:6774-91 pubmed 出版商
  249. Quintero Barceinas R, García Regalado A, Aréchaga Ocampo E, Villegas Sepúlveda N, González De la Rosa C. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism. Biomed Res Int. 2015;2015:404368 pubmed 出版商
  250. Ksionda O, Melton A, Bache J, Tenhagen M, Bakker J, Harvey R, et al. RasGRP1 overexpression in T-ALL increases basal nucleotide exchange on Ras rendering the Ras/PI3K/Akt pathway responsive to protumorigenic cytokines. Oncogene. 2016;35:3658-68 pubmed 出版商
  251. Yen Y, Hsiao J, Jiang S, Chang J, Wang S, Shen Y, et al. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1. Oncotarget. 2015;6:41837-55 pubmed 出版商
  252. Vernot J, Perdomo Arciniegas A, Pérez Quintero L, Martínez D. Modulating p56Lck in T-Cells by a Chimeric Peptide Comprising Two Functionally Different Motifs of Tip from Herpesvirus saimiri. J Immunol Res. 2015;2015:395371 pubmed 出版商
  253. Li W, Wei S, Liu C, Song M, Wu H, Yang Y. Regulation of the osteogenic and adipogenic differentiation of bone marrow-derived stromal cells by extracellular uridine triphosphate: The role of P2Y2 receptor and ERK1/2 signaling. Int J Mol Med. 2016;37:63-73 pubmed 出版商
  254. Freedman T, Tan Y, Skrzypczynska K, Manz B, Sjaastad F, Goodridge H, et al. LynA regulates an inflammation-sensitive signaling checkpoint in macrophages. elife. 2015;4: pubmed 出版商
  255. Sipieter F, Cappe B, Gonzalez Pisfil M, Spriet C, Bodart J, Cailliau Maggio K, et al. Novel Reporter for Faithful Monitoring of ERK2 Dynamics in Living Cells and Model Organisms. PLoS ONE. 2015;10:e0140924 pubmed 出版商
  256. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed 出版商
  257. Wu S, Guo Z, Hopkins C, Wei N, Chu E, Wipf P, et al. Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells. Oncotarget. 2015;6:40866-79 pubmed 出版商
  258. Ramcharan R, Aleksic T, Kamdoum W, Gao S, Pfister S, Tanner J, et al. IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide. Oncotarget. 2015;6:39877-90 pubmed 出版商
  259. Moncunill Massaguer C, Saura Esteller J, Pérez Perarnau A, Palmeri C, Núñez Vázquez S, Cosialls A, et al. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget. 2015;6:41750-65 pubmed 出版商
  260. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed 出版商
  261. Hruska M, Henderson N, Xia N, Le Marchand S, Dalva M. Anchoring and synaptic stability of PSD-95 is driven by ephrin-B3. Nat Neurosci. 2015;18:1594-605 pubmed 出版商
  262. Barbáchano A, Fernández Barral A, Pereira F, Segura M, Ordóñez Morán P, Carrillo de Santa Pau E, et al. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150. Oncogene. 2016;35:2991-3003 pubmed 出版商
  263. Salas E, Roy S, Marsh T, Rubin B, Debnath J. Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death. Oncogene. 2016;35:2913-22 pubmed 出版商
  264. Kim H, Lim J, Kim J, Kim Y, Park S, Sohn J. Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models. Int J Cancer. 2016;138:1432-41 pubmed 出版商
  265. Liu L, Li C, Lu Y, Zong X, Luo C, Sun J, et al. Baclofen mediates neuroprotection on hippocampal CA1 pyramidal cells through the regulation of autophagy under chronic cerebral hypoperfusion. Sci Rep. 2015;5:14474 pubmed 出版商
  266. Sun Y, Ju M, Lin Z, Fredrick T, Evans L, Tian K, et al. SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth. Sci Signal. 2015;8:ra94 pubmed 出版商
  267. Pearson H, McGlinn E, Phesse T, Schlüter H, Srikumar A, Gödde N, et al. The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis. Mol Cancer. 2015;14:169 pubmed 出版商
  268. Davare M, Vellore N, Wagner J, Eide C, Goodman J, Drilon A, et al. Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors. Proc Natl Acad Sci U S A. 2015;112:E5381-90 pubmed 出版商
  269. Xing R, Li L, Chen L, Gao Z, Wang H, Li W, et al. Copy number variations of HLA-I and activation of NKp30 pathway determine the sensitivity of gastric cancer cells to the cytotoxicity of natural killer cells. Oncogene. 2016;35:2584-91 pubmed 出版商
  270. Ramírez de Arellano A, Lopez Pulido E, Martínez Neri P, Estrada Chávez C, González Lucano R, Fafutis Morris M, et al. STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells. Cancer Cell Int. 2015;15:83 pubmed 出版商
  271. Zhou X, Tao Y, Liang C, Zhang Y, Li H, Chen Q. BMP3 Alone and Together with TGF-β Promote the Differentiation of Human Mesenchymal Stem Cells into a Nucleus Pulposus-Like Phenotype. Int J Mol Sci. 2015;16:20344-59 pubmed 出版商
  272. Georgiannakis A, Burgoyne T, Lueck K, Futter C, Greenwood J, Moss S. Retinal Pigment Epithelial Cells Mitigate the Effects of Complement Attack by Endocytosis of C5b-9. J Immunol. 2015;195:3382-9 pubmed 出版商
  273. Gong Y, Qiu W, Ning X, Yang X, Liu L, Wang Z, et al. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration. Oncotarget. 2015;6:25856-67 pubmed 出版商
  274. Kumarasamy V, Shin Y, White J, Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599 pubmed 出版商
  275. Wong T, Lin S, Leung L. The Flavone Luteolin Suppresses SREBP-2 Expression and Post-Translational Activation in Hepatic Cells. PLoS ONE. 2015;10:e0135637 pubmed 出版商
  276. Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, et al. Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis. Cancer Sci. 2015;106:1596-606 pubmed 出版商
  277. Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature. 2015;525:389-393 pubmed 出版商
  278. Park E, Kim N, Ficarro S, Zhang Y, Lee B, Cho A, et al. Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6. Nat Struct Mol Biol. 2015;22:703-711 pubmed 出版商
  279. Sivaraj K, Li R, Albarrán Juárez J, Wang S, Tischner D, Grimm M, et al. Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis. Cardiovasc Res. 2015;108:171-80 pubmed 出版商
  280. Kim K, Byeon G, Kim H, Baek S, Shin S, Koo S. Mechanical Antiallodynic Effect of Intrathecal Nefopam in a Rat Neuropathic Pain Model. J Korean Med Sci. 2015;30:1189-96 pubmed 出版商
  281. Wu M, Lee W, Hua K, Kuo M, Lin M. Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the β-Catenin Pathway. PLoS ONE. 2015;10:e0134122 pubmed 出版商
  282. Zhang W, Zheng X, Du L, Sun J, Shen Z, Shi C, et al. High salt primes a specific activation state of macrophages, M(Na). Cell Res. 2015;25:893-910 pubmed 出版商
  283. Zou Q, Jin J, Xiao Y, Hu H, Zhou X, Jie Z, et al. T cell development involves TRAF3IP3-mediated ERK signaling in the Golgi. J Exp Med. 2015;212:1323-36 pubmed 出版商
  284. García Pérez D, Laorden M, Milanés M. Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration. Int J Neuropsychopharmacol. 2015;19: pubmed 出版商
  285. Gorojod R, Alaimo A, Porte Alcon S, Pomilio C, Saravia F, Kotler M. The autophagic- lysosomal pathway determines the fate of glial cells under manganese- induced oxidative stress conditions. Free Radic Biol Med. 2015;87:237-51 pubmed 出版商
  286. Yang S, Lin H, Chang V, Chen C, Liu Y, Wang J, et al. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo. Oncotarget. 2015;6:23857-73 pubmed
  287. Xiong H, Zhou S, Sun A, He Y, Li J, Yuan X. MicroRNA‑197 reverses the drug resistance of fluorouracil‑induced SGC7901 cells by targeting mitogen‑activated protein kinase 1. Mol Med Rep. 2015;12:5019-25 pubmed 出版商
  288. Chen K, Tsai M, Wu C, Jou M, Wei I, Huang C. AMPA Receptor-mTOR Activation is Required for the Antidepressant-Like Effects of Sarcosine during the Forced Swim Test in Rats: Insertion of AMPA Receptor may Play a Role. Front Behav Neurosci. 2015;9:162 pubmed 出版商
  289. Seo G, Ho M, Bui N, Kim Y, Koh D, Lim Y, et al. Novel naphthochalcone derivative accelerate dermal wound healing through induction of epithelial-mesenchymal transition of keratinocyte. J Biomed Sci. 2015;22:47 pubmed 出版商
  290. He L, Zang A, Du M, Ma D, Yuan C, Zhou C, et al. mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines. Virol Sin. 2015;30:174-89 pubmed 出版商
  291. Noda K, Mishina Y, Komatsu Y. Constitutively active mutation of ACVR1 in oral epithelium causes submucous cleft palate in mice. Dev Biol. 2016;415:306-313 pubmed 出版商
  292. Roda D, Castillo J, Telechea Fernández M, Gil A, López Rodas G, Franco L, et al. EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells. PLoS ONE. 2015;10:e0130543 pubmed 出版商
  293. Pickard A, McDade S, McFarland M, McCluggage W, Wheeler C, McCance D. HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures. PLoS Pathog. 2015;11:e1004988 pubmed 出版商
  294. Choi J, Kim J, Kim T, Park J, Lee J, Kim H, et al. TRH and TRH receptor system in the basolateral amygdala mediate stress-induced depression-like behaviors. Neuropharmacology. 2015;97:346-56 pubmed 出版商
  295. Chen M, Yen C, Cheng C, Wu R, Huang S, Yu C, et al. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. Oncotarget. 2015;6:23594-608 pubmed
  296. Faggi F, Codenotti S, Poliani P, Cominelli M, Chiarelli N, Colombi M, et al. MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line. PLoS ONE. 2015;10:e0130287 pubmed 出版商
  297. Gopinathan G, Milagre C, Pearce O, Reynolds L, Hodivala Dilke K, Leinster D, et al. Interleukin-6 Stimulates Defective Angiogenesis. Cancer Res. 2015;75:3098-107 pubmed 出版商
  298. Hensel J, Duex J, Owens C, Dancik G, Edwards M, Frierson H, et al. Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors. Mol Cancer Res. 2015;13:1306-15 pubmed 出版商
  299. Lee W, Shen S, Shih Y, Chou C, Tseng J, Chin S, et al. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts. J Transl Med. 2015;13:191 pubmed 出版商
  300. Unni A, Lockwood W, Zejnullahu K, Lee Lin S, Varmus H. Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. elife. 2015;4:e06907 pubmed 出版商
  301. Wightman S, Uppal A, Pitroda S, Ganai S, Burnette B, Stack M, et al. Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br J Cancer. 2015;113:327-35 pubmed 出版商
  302. García Cano J, Ambroise G, Pascual Serra R, Carrión M, Serrano Oviedo L, Ortega Muelas M, et al. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance. Oncotarget. 2015;6:15551-65 pubmed
  303. Boeldt D, Grummer M, YI F, Magness R, Bird I. Phosphorylation of Ser-279/282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells. Mol Cell Endocrinol. 2015;412:73-84 pubmed 出版商
  304. Tampella G, Kerns H, Niu D, Singh S, Khim S, Bosch K, et al. The Tec Kinase-Regulated Phosphoproteome Reveals a Mechanism for the Regulation of Inhibitory Signals in Murine Macrophages. J Immunol. 2015;195:246-56 pubmed 出版商
  305. Li T, Lu H, Mukherjee D, Lahiri S, Shen C, Yu L, et al. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer. Oncotarget. 2015;6:21428-42 pubmed
  306. Luan Q, Jin L, Jiang C, Tay K, Lai F, Liu X, et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy. 2015;11:975-94 pubmed 出版商
  307. Yen C, Chiang W, Liu S, Lin C, Liao K, Lin C, et al. Impacts of autophagy-inducing ingredient of areca nut on tumor cells. PLoS ONE. 2015;10:e0128011 pubmed 出版商
  308. Korotkevych N, Labyntsev A, Kolybo D, Komisarenko S. The Soluble Heparin-Binding EGF-Like Growth Factor Stimulates EGF Receptor Trafficking to the Nucleus. PLoS ONE. 2015;10:e0127887 pubmed 出版商
  309. Alexandrova E, Yallowitz A, Li D, Xu S, Schulz R, Proia D, et al. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature. 2015;523:352-6 pubmed 出版商
  310. Reigada D, Nieto Díaz M, Navarro Ruiz R, Caballero López M, Del Águila A, Muñoz Galdeano T, et al. Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury. Neuroscience. 2015;300:404-17 pubmed 出版商
  311. Bargut T, Mandarim de Lacerda C, Aguila M. A high-fish-oil diet prevents adiposity and modulates white adipose tissue inflammation pathways in mice. J Nutr Biochem. 2015;26:960-9 pubmed 出版商
  312. Greenfeld H, Takasaki K, Walsh M, Ersing I, Bernhardt K, Ma Y, et al. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation. PLoS Pathog. 2015;11:e1004890 pubmed 出版商
  313. Li P, Sheu M, Ma W, Pan C, Sheu J, Wu C. Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells. Mar Drugs. 2015;13:3046-60 pubmed 出版商
  314. Pan D, Jiang C, Ma Z, Blonska M, You M, Lin X. MALT1 is required for EGFR-induced NF-?B activation and contributes to EGFR-driven lung cancer progression. Oncogene. 2016;35:919-28 pubmed 出版商
  315. Ji X, Li Z, Chen H, Li J, Tian H, Li Z, et al. Cytotoxic mechanism related to dihydrolipoamide dehydrogenase in Leydig cells exposed to heavy metals. Toxicology. 2015;334:22-32 pubmed 出版商
  316. Wong T, Lin S, Leung L. The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68. Br J Nutr. 2015;113:1844-52 pubmed 出版商
  317. Ketema M, Secades P, Kreft M, Nahidiazar L, Janssen H, Jalink K, et al. The rod domain is not essential for the function of plectin in maintaining tissue integrity. Mol Biol Cell. 2015;26:2402-17 pubmed 出版商
  318. Andersen N, Boguslawski E, Kuk C, Chambers C, Duesbery N. Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts. Int J Oncol. 2015;47:71-80 pubmed 出版商
  319. Cong X, Zhang Y, Li J, Mei M, Ding C, Xiang R, et al. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. J Cell Sci. 2015;128:2271-86 pubmed 出版商
  320. Rios Doria J, Sabol D, Chesebrough J, Stewart D, Xu L, Tammali R, et al. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways. Mol Cancer Ther. 2015;14:1637-49 pubmed 出版商
  321. Waters A, Stewart J, Atigadda V, Mroczek Musulman E, Muccio D, Grubbs C, et al. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma. Mol Cancer Ther. 2015;14:1559-69 pubmed 出版商
  322. Yu Y, Koehn C, Yue Y, Li S, Thiele G, Hearth Holmes M, et al. Celastrol inhibits inflammatory stimuli-induced neutrophil extracellular trap formation. Curr Mol Med. 2015;15:401-10 pubmed
  323. Lee E, Park E, Mun H, Chang E, Ko J, Kim D, et al. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation. FASEB J. 2015;29:3506-14 pubmed 出版商
  324. Bhang S, Han J, Jang H, Noh M, La W, Yi M, et al. pH-triggered release of manganese from MnAu nanoparticles that enables cellular neuronal differentiation without cellular toxicity. Biomaterials. 2015;55:33-43 pubmed 出版商
  325. SCANLON C, Banerjee R, Inglehart R, Liu M, Russo N, Hariharan A, et al. Galanin modulates the neural niche to favour perineural invasion in head and neck cancer. Nat Commun. 2015;6:6885 pubmed 出版商
  326. Pasqualon T, Pruessmeyer J, Weidenfeld S, Babendreyer A, Groth E, Schumacher J, et al. A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation. Cell Mol Life Sci. 2015;72:3783-801 pubmed 出版商
  327. Daniele S, Da Pozzo E, Zappelli E, Martini C. Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-?B, p38 and JNK. Cell Signal. 2015;27:1609-29 pubmed 出版商
  328. Chan S, Selth L, Li Y, Nyquist M, Miao L, Bradner J, et al. Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies. Nucleic Acids Res. 2015;43:5880-97 pubmed 出版商
  329. Huang L, Counter C. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S. PLoS ONE. 2015;10:e0123918 pubmed 出版商
  330. Yang Z, Zheng B, Zhang Y, He M, Zhang X, Ma D, et al. miR-155-dependent regulation of mammalian sterile 20-like kinase 2 (MST2) coordinates inflammation, oxidative stress and proliferation in vascular smooth muscle cells. Biochim Biophys Acta. 2015;1852:1477-89 pubmed 出版商
  331. Selvaraj N, Kedage V, Hollenhorst P. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells. Cell Commun Signal. 2015;13:12 pubmed 出版商
  332. Hayashi Y, Bardsley M, Toyomasu Y, Milosavljevic S, Gajdos G, Choi K, et al. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1. Gastroenterology. 2015;149:420-32.e16 pubmed 出版商
  333. Navis A, van Lith S, van Duijnhoven S, de Pooter M, Yetkin Arik B, Wesseling P, et al. Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein. Acta Neuropathol. 2015;130:131-44 pubmed 出版商
  334. Witkiewicz A, McMillan E, Balaji U, Baek G, Lin W, Mansour J, et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015;6:6744 pubmed 出版商
  335. Kim T, Lawson M. GnRH Regulates Gonadotropin Gene Expression Through NADPH/Dual Oxidase-Derived Reactive Oxygen Species. Endocrinology. 2015;156:2185-99 pubmed 出版商
  336. Boncompagni S, Arthurton L, Akujuru E, Pearson T, Steverding D, Protasi F, et al. Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres. J Physiol. 2015;593:2679-92 pubmed 出版商
  337. Chan N, He S, Spee C, Ishikawa K, Hinton D. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLoS ONE. 2015;10:e0120587 pubmed 出版商
  338. Zhang Q, Kuang H, Chen C, Yan J, Do Umehara H, Liu X, et al. The kinase Jnk2 promotes stress-induced mitophagy by targeting the small mitochondrial form of the tumor suppressor ARF for degradation. Nat Immunol. 2015;16:458-66 pubmed 出版商
  339. Kumar A, Pathak P, Purkait S, Faruq M, Jha P, Mallick S, et al. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas. Cancer Genet. 2015;208:91-5 pubmed 出版商
  340. Muro R, Nitta T, Okada T, Ideta H, Tsubata T, Suzuki H. The Ras GTPase-activating protein Rasal3 supports survival of naive T cells. PLoS ONE. 2015;10:e0119898 pubmed 出版商
  341. Kawada M, Inoue H, Ohba S, Yoshida J, Masuda T, Yamasaki M, et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS ONE. 2015;10:e0119415 pubmed 出版商
  342. Carnesecchi J, Malbouyres M, de Mets R, Balland M, Beauchef G, Vié K, et al. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30. PLoS ONE. 2015;10:e0120672 pubmed 出版商
  343. Qu D, Chen Y, Xu X, Zhang M, Zhang Y, Li S. Cbl-b-regulated extracellular signal-regulated kinase signaling is involved in the shikonin-induced apoptosis of lung cancer cells in vitro. Exp Ther Med. 2015;9:1265-1270 pubmed
  344. Wang B, Wu S, Tang S, Lai C, Ou C, Wu M, et al. Benzo[a]pyrene-induced cell cycle progression occurs via ERK-induced Chk1 pathway activation in human lung cancer cells. Mutat Res. 2015;773:1-8 pubmed 出版商
  345. Münzberg C, Höhn K, Krndija D, Maaß U, Bartsch D, Slater E, et al. IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells. J Cell Mol Med. 2015;19:948-59 pubmed 出版商
  346. Warren D, Tajsic T, Porter L, Minaisah R, Cobb A, Jacob A, et al. Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing. Cell Death Differ. 2015;22:1540-50 pubmed 出版商
  347. Silva G, Aboussekhra A. p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1. Mol Carcinog. 2016;55:525-36 pubmed 出版商
  348. Wnorowski A, Sadowska M, Paul R, Singh N, Boguszewska Czubara A, Jimenez L, et al. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells. Cell Signal. 2015;27:997-1007 pubmed 出版商
  349. Murrow L, Malhotra R, Debnath J. ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 2015;17:300-10 pubmed 出版商
  350. Skarra D, Thackray V. FOXO1 is regulated by insulin and IGF1 in pituitary gonadotropes. Mol Cell Endocrinol. 2015;405:14-24 pubmed 出版商
  351. Momeny M, Saunus J, Marturana F, McCart Reed A, Black D, Sala G, et al. Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines. Oncotarget. 2015;6:3932-46 pubmed
  352. Fouladi F, Jehn L, Metzelder S, Hub F, Henkenius K, Burchert A, et al. Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation. Leuk Lymphoma. 2015;56:2690-8 pubmed 出版商
  353. Castorina A, Waschek J, Marzagalli R, Cardile V, Drago F. PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures. PLoS ONE. 2015;10:e0117799 pubmed 出版商
  354. Papadakis A, Sun C, Knijnenburg T, Xue Y, Grernrum W, Hölzel M, et al. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Res. 2015;25:445-58 pubmed 出版商
  355. Bai L, Mao R, Wang J, Ding L, Jiang S, Gao C, et al. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. Med Oncol. 2015;32:57 pubmed 出版商
  356. Shaw A, Pickup M, Chytil A, Aakre M, Owens P, Moses H, et al. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions. PLoS ONE. 2015;10:e0117908 pubmed 出版商
  357. Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim J, et al. The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells. Cell Cycle. 2015;14:990-1000 pubmed 出版商
  358. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz E, Cappello A, et al. Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts. Environ Health Perspect. 2015;123:493-9 pubmed 出版商
  359. Tian E, Stevens S, Guan Y, Springer D, Anderson S, Starost M, et al. Galnt1 is required for normal heart valve development and cardiac function. PLoS ONE. 2015;10:e0115861 pubmed 出版商
  360. Seaberg B, Henslee G, Wang S, Paez Colasante X, Landreth G, Rimer M. Muscle-derived extracellular signal-regulated kinases 1 and 2 are required for the maintenance of adult myofibers and their neuromuscular junctions. Mol Cell Biol. 2015;35:1238-53 pubmed 出版商
  361. Tontonoz P, Cortez Toledo O, Wroblewski K, Hong C, Lim L, Carranza R, et al. The orphan nuclear receptor Nur77 is a determinant of myofiber size and muscle mass in mice. Mol Cell Biol. 2015;35:1125-38 pubmed 出版商
  362. Schäker K, Bartsch S, Patry C, Stoll S, Hillebrands J, Wieland T, et al. The bipartite rac1 Guanine nucleotide exchange factor engulfment and cell motility 1/dedicator of cytokinesis 180 (elmo1/dock180) protects endothelial cells from apoptosis in blood vessel development. J Biol Chem. 2015;290:6408-18 pubmed 出版商
  363. de Oliveira S, Boudinot P, Calado Ã, Mulero V. Duox1-derived H2O2 modulates Cxcl8 expression and neutrophil recruitment via JNK/c-JUN/AP-1 signaling and chromatin modifications. J Immunol. 2015;194:1523-33 pubmed 出版商
  364. Majuelos Melguizo J, Rodríguez M, López Jiménez L, Rodríguez Vargas J, Martí Martín Consuegra J, Serrano Sáenz S, et al. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Oncotarget. 2015;6:4790-803 pubmed
  365. Sathyamurthy A, Yin D, Barik A, Shen C, Bean J, Figueiredo D, et al. ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination. Development. 2015;142:522-32 pubmed 出版商
  366. Wang H, Zhu X, Qin L, Qian H, Wang Y. Microglia activity modulated by T cell Ig and mucin domain protein 3 (Tim-3). Cell Immunol. 2015;293:49-58 pubmed 出版商
  367. Zanotto Filho A, Braganhol E, Klafke K, Figueiró F, Terra S, Paludo F, et al. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett. 2015;358:220-31 pubmed 出版商
  368. Gonzalez Granado J, Navarro Puche A, Molina Sánchez P, Blanco Berrocal M, Viana R, Font de Mora J, et al. Sorting nexin 6 enhances lamin a synthesis and incorporation into the nuclear envelope. PLoS ONE. 2014;9:e115571 pubmed 出版商
  369. Salotti J, Sakchaisri K, Tourtellotte W, Johnson P. An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer. Mol Cell Biol. 2015;35:866-83 pubmed 出版商
  370. Passos E, Pereira C, Gonçalves I, Rocha Rodrigues S, Silva N, Guimarães J, et al. Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. Life Sci. 2015;123:51-60 pubmed 出版商
  371. Kim E, Kim S, Jin X, Ham S, Kim J, Park J, et al. Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1. Tumour Biol. 2015;36:2921-8 pubmed 出版商
  372. Narumi K, Hirose T, Sato E, Mori T, Kisu K, Ishikawa M, et al. A functional (pro)renin receptor is expressed in human lymphocytes and monocytes. Am J Physiol Renal Physiol. 2015;308:F487-99 pubmed 出版商
  373. Bifsha P, Yang J, Fisher R, Drouin J. Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra. PLoS Genet. 2014;10:e1004863 pubmed 出版商
  374. Girotti M, Lopes F, Preece N, Niculescu Duvaz D, Zambon A, Davies L, et al. Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma. Cancer Cell. 2015;27:85-96 pubmed 出版商
  375. Delloye Bourgeois C, Jacquier A, Charoy C, Reynaud F, Nawabi H, Thoinet K, et al. PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. Nat Neurosci. 2015;18:36-45 pubmed 出版商
  376. Bernusso V, Machado Neto J, Pericole F, Vieira K, Duarte A, Traina F, et al. Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochim Biophys Acta. 2015;1853:388-95 pubmed 出版商
  377. Xu T, Pan Z, Dong M, Yu C, Niu Y. Ferulic acid suppresses activation of hepatic stellate cells through ERK1/2 and Smad signaling pathways in vitro. Biochem Pharmacol. 2015;93:49-58 pubmed 出版商
  378. Tang D, Yu Y, Zhao X, Schachner M, Zhao W. Single chain fragment variable antibodies developed by using as target the 3rd fibronectin type III homologous repeat fragment of human neural cell adhesion molecule L1 promote cell migration and neuritogenesis. Exp Cell Res. 2015;330:336-45 pubmed 出版商
  379. Olayanju A, Copple I, Bryan H, Edge G, Sison R, Wong M, et al. Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2. Free Radic Biol Med. 2015;78:202-12 pubmed 出版商
  380. Giovannini C, Minguzzi M, Baglioni M, Fornari F, Giannone F, Ravaioli M, et al. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. Oncotarget. 2014;5:10607-20 pubmed
  381. Heynen G, Fonfara A, Bernards R. Resistance to targeted cancer drugs through hepatocyte growth factor signaling. Cell Cycle. 2014;13:3808-17 pubmed 出版商
  382. Janardhan S, Marks R, Gajewski T. Primary murine CD4+ T cells fail to acquire the ability to produce effector cytokines when active Ras is present during Th1/Th2 differentiation. PLoS ONE. 2014;9:e112831 pubmed 出版商
  383. Huang L, Carney J, Cardona D, Counter C. Decreased tumorigenesis in mice with a Kras point mutation at C118. Nat Commun. 2014;5:5410 pubmed 出版商
  384. Blaabjerg L, Christensen G, Matsumoto M, van der Meulen T, Huising M, Billestrup N, et al. CRFR1 activation protects against cytokine-induced β-cell death. J Mol Endocrinol. 2014;53:417-27 pubmed 出版商
  385. Huertas Martínez J, Rello Varona S, Herrero Martín D, Barrau I, García Monclús S, Sáinz Jaspeado M, et al. Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth. Oncotarget. 2014;5:9744-55 pubmed
  386. Rutkowska A, Preuss I, Gessier F, Sailer A, Dev K. EBI2 regulates intracellular signaling and migration in human astrocyte. Glia. 2015;63:341-51 pubmed 出版商
  387. Rai S, Tanaka H, Suzuki M, Ogoh H, Taniguchi Y, Morita Y, et al. Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells. PLoS ONE. 2014;9:e109441 pubmed 出版商
  388. Wang Y, Kuramitsu Y, Tokuda K, Baron B, Kitagawa T, Akada J, et al. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. PLoS ONE. 2014;9:e109076 pubmed 出版商
  389. Kannike K, Sepp M, Zuccato C, Cattaneo E, Timmusk T. Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop. J Biol Chem. 2014;289:32845-57 pubmed 出版商
  390. Zhang X, Zhang Q, Tu J, Zhu Y, Yang F, Liu B, et al. Prosurvival NMDA 2A receptor signaling mediates postconditioning neuroprotection in the hippocampus. Hippocampus. 2015;25:286-96 pubmed 出版商
  391. Zhou X, Tao Y, Wang J, Liang C, Wang J, Li H, et al. Roles of FGF-2 and TGF-beta/FGF-2 on differentiation of human mesenchymal stem cells towards nucleus pulposus-like phenotype. Growth Factors. 2015;33:23-30 pubmed 出版商
  392. Zhu X, Zhao L, Park J, Willingham M, Cheng S. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation. Neoplasia. 2014;16:757-69 pubmed 出版商
  393. Dou W, Zhang J, Ren G, Ding L, Sun A, Deng C, et al. Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation. Int Immunopharmacol. 2014;23:170-8 pubmed 出版商
  394. Pilchova I, Klacanova K, Chomova M, Tatarkova Z, Dobrota D, Racay P. Possible contribution of proteins of Bcl-2 family in neuronal death following transient global brain ischemia. Cell Mol Neurobiol. 2015;35:23-31 pubmed 出版商
  395. Candelaria N, Addanki S, Zheng J, Nguyen Vu T, Karaboga H, Dey P, et al. Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS ONE. 2014;9:e106289 pubmed 出版商
  396. Tang J, Shen L, Yang Q, Zhang C. Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif. 2014;47:427-34 pubmed 出版商
  397. Sa S, Wong L, McCloskey K. Combinatorial fibronectin and laminin signaling promote highly efficient cardiac differentiation of human embryonic stem cells. Biores Open Access. 2014;3:150-61 pubmed 出版商
  398. Han P, Zhou X, Chang N, Xiao C, Yan S, Ren H, et al. Hydrogen peroxide primes heart regeneration with a derepression mechanism. Cell Res. 2014;24:1091-107 pubmed 出版商
  399. Li L, Wu P, Lee J, Li P, Hsieh W, Ho C, et al. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells. PLoS ONE. 2014;9:e104203 pubmed 出版商
  400. Zhang S, Ren M, Zeng X, He P, Ma X, Qiao S. Leucine stimulates ASCT2 amino acid transporter expression in porcine jejunal epithelial cell line (IPEC-J2) through PI3K/Akt/mTOR and ERK signaling pathways. Amino Acids. 2014;46:2633-42 pubmed 出版商
  401. Watanabe T, Nakamura S, Ono T, Ui S, Yagi S, Kagawa H, et al. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma. Biochem Biophys Res Commun. 2014;451:93-100 pubmed 出版商
  402. Castorina A, Giunta S. Mucin 1 (MUC1) signalling contributes to increase the resistance to cell death in human bronchial epithelial cells exposed to nickel acetate. Biometals. 2014;27:1149-58 pubmed 出版商
  403. Wu T, Ye Y, Min S, Zhu J, Khobahy E, Zhou J, et al. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Arthritis Rheumatol. 2014;66:3129-39 pubmed 出版商
  404. Kugel C, Hartsough E, Davies M, Setiady Y, Aplin A. Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitor. Cancer Res. 2014;74:4122-32 pubmed 出版商
  405. Kapur N, Qiao X, Paruchuri V, Mackey E, Daly G, Ughreja K, et al. Reducing endoglin activity limits calcineurin and TRPC-6 expression and improves survival in a mouse model of right ventricular pressure overload. J Am Heart Assoc. 2014;3: pubmed 出版商
  406. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, et al. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Eur J Cancer. 2014;50:2336-50 pubmed 出版商
  407. Ribeiro M, Rosenstock T, Oliveira A, Oliveira C, Rego A. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. Free Radic Biol Med. 2014;74:129-44 pubmed 出版商
  408. Liu J, Ke F, Xu Z, Liu Z, Zhang L, Yan S, et al. CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo. PLoS ONE. 2014;9:e101137 pubmed 出版商
  409. Chang P, Hung C, Wang S, Tsai P, Shih Y, Chen L, et al. Identification and characterization of two novel spliced genes located in the orf47-orf46-orf45 gene locus of Kaposi's sarcoma-associated herpesvirus. J Virol. 2014;88:10092-109 pubmed 出版商
  410. Rathore K, Cekanova M. Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines. BMC Cancer. 2014;14:465 pubmed 出版商
  411. Ishikawa D, Shimada M, Utsunomiya T, Morine Y, Imura S, Ikemoto T, et al. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol Hepatol. 2014;29:2032-7 pubmed 出版商
  412. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed 出版商
  413. Zielniok K, Motyl T, Gajewska M. Functional interactions between 17 ? -estradiol and progesterone regulate autophagy during acini formation by bovine mammary epithelial cells in 3D cultures. Biomed Res Int. 2014;2014:382653 pubmed 出版商
  414. Mena H, Lokajczyk A, Dizier B, Strier S, Voto L, Boisson Vidal C, et al. Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells. Angiogenesis. 2014;17:867-79 pubmed 出版商
  415. Attarha S, Andersson S, Mints M, Souchelnytskyi S. Mammalian sterile-like 1 kinase inhibits TGF? and EGF?dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells. Int J Oncol. 2014;45:853-60 pubmed 出版商
  416. Kardos G, Dai M, Robertson G. Growth inhibitory effects of large subunit ribosomal proteins in melanoma. Pigment Cell Melanoma Res. 2014;27:801-12 pubmed 出版商
  417. Jiang Y, Kou Z, Wu T, An W, Zhou R, Wang H, et al. Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion. Stem Cells Dev. 2014;23:2283-96 pubmed 出版商
  418. Cazanave S, Wang X, Zhou H, Rahmani M, Grant S, Durrant D, et al. Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis. Cell Death Differ. 2014;21:1303-12 pubmed 出版商
  419. Ost M, Werner F, Dokas J, Klaus S, Voigt A. Activation of AMPK?2 is not crucial for mitochondrial uncoupling-induced metabolic effects but required to maintain skeletal muscle integrity. PLoS ONE. 2014;9:e94689 pubmed 出版商
  420. Kerdivel G, Boudot A, Habauzit D, Percevault F, Demay F, Pakdel F, et al. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines. Mol Cell Endocrinol. 2014;390:34-44 pubmed 出版商
  421. Gürtler C, Carty M, Kearney J, Schattgen S, Ding A, Fitzgerald K, et al. SARM regulates CCL5 production in macrophages by promoting the recruitment of transcription factors and RNA polymerase II to the Ccl5 promoter. J Immunol. 2014;192:4821-32 pubmed 出版商
  422. Lamprecht M, Morrison B. GPR30 activation is neither necessary nor sufficient for acute neuroprotection by 17?-estradiol after an ischemic injury in organotypic hippocampal slice cultures. Brain Res. 2014;1563:131-7 pubmed 出版商
  423. Guerra M, Wauson E, McGlynn K, Cobb M. Muscarinic control of MIN6 pancreatic ? cells is enhanced by impaired amino acid signaling. J Biol Chem. 2014;289:14370-9 pubmed 出版商
  424. Anchan D, Clark S, Pollard K, Vasudevan N. GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice. Brain Behav. 2014;4:51-9 pubmed 出版商
  425. Singel S, Batten K, Cornelius C, Jia G, Fasciani G, Barron S, et al. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways. Breast Cancer Res. 2014;16:R28 pubmed 出版商
  426. Tsai Y, Wang C, Leung P, Lin K, Chio C, Hu C, et al. Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model. J Surg Res. 2014;189:106-16 pubmed 出版商
  427. Wei N, Chu E, Wipf P, Schmitz J. Protein kinase d as a potential chemotherapeutic target for colorectal cancer. Mol Cancer Ther. 2014;13:1130-41 pubmed 出版商
  428. Yu P, Laird A, Du X, Wu J, Won K, Yamaguchi K, et al. Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway. Mol Cancer Ther. 2014;13:1078-91 pubmed 出版商
  429. Wang Q, Shen B, Chen L, Zheng P, Feng H, Hao Q, et al. Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis. Oncogene. 2015;34:1006-18 pubmed 出版商
  430. Bokobza S, Jiang Y, Weber A, Devery A, Ryan A. Short-course treatment with gefitinib enhances curative potential of radiation therapy in a mouse model of human non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;88:947-54 pubmed 出版商
  431. Cheng C, Lin J, Su S, Tang N, Kao S, Hsieh C. Electroacupuncture-like stimulation at Baihui and Dazhui acupoints exerts neuroprotective effects through activation of the brain-derived neurotrophic factor-mediated MEK1/2/ERK1/2/p90RSK/bad signaling pathway in mild transient focal cerebral ischemi. BMC Complement Altern Med. 2014;14:92 pubmed 出版商
  432. Okada T, Nitta T, Kaji K, Takashima A, Oda H, Tamehiro N, et al. Differential function of Themis CABIT domains during T cell development. PLoS ONE. 2014;9:e89115 pubmed 出版商
  433. Son J, Jeong H, Kim H, Kim Y, Lee E, Lee H, et al. Pelargonidin attenuates PDGF-BB-induced aortic smooth muscle cell proliferation and migration by direct inhibition of focal adhesion kinase. Biochem Pharmacol. 2014;89:236-45 pubmed 出版商
  434. Ihunnah C, Wada T, Philips B, Ravuri S, Gibbs R, Kirisci L, et al. Estrogen sulfotransferase/SULT1E1 promotes human adipogenesis. Mol Cell Biol. 2014;34:1682-94 pubmed 出版商
  435. Okada N, Lin C, Ribeiro M, Biton A, Lai G, He X, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 2014;28:438-50 pubmed 出版商
  436. Wang Y, Kuramitsu Y, Tokuda K, Okada F, Baron B, Akada J, et al. Proteomic analysis indicates that overexpression and nuclear translocation of lactoylglutathione lyase (GLO1) is associated with tumor progression in murine fibrosarcoma. Electrophoresis. 2014;35:2195-202 pubmed 出版商
  437. Feng C, Zhang Y, Yin J, Li J, Abounader R, Zuo Z. Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro Oncol. 2014;16:1078-85 pubmed 出版商
  438. Park E, Kim B, Lee E, Chang E, Kim D, Choi S, et al. Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease. J Biol Chem. 2014;289:9254-62 pubmed 出版商
  439. Lee M, Smith S, Murray S, Pham L, Minoo P, Nielsen H. Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts. Am J Respir Cell Mol Biol. 2014;51:114-24 pubmed 出版商
  440. Jin Y, Wi H, Choi M, Hong S, Bae Y. Regulation of anti-inflammatory cytokines IL-10 and TGF-? in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med. 2014;46:e74 pubmed 出版商
  441. Gámez M, Calvo M, Selgas M, García M, Erler K, Böhm V, et al. Effect of E-beam treatment on the chemistry and on the antioxidant activity of lycopene from dry tomato peel and tomato powder. J Agric Food Chem. 2014;62:1557-63 pubmed 出版商
  442. Joannes A, Grelet S, Duca L, Gilles C, Kileztky C, Dalstein V, et al. Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells. Mol Cancer Res. 2014;12:775-83 pubmed 出版商
  443. Valdez Magaña G, Rodriguez A, Zhang H, Webb R, Alberio R. Paracrine effects of embryo-derived FGF4 and BMP4 during pig trophoblast elongation. Dev Biol. 2014;387:15-27 pubmed 出版商
  444. Murcia Belmonte V, Medina Rodríguez E, Bribian A, De Castro F, Esteban P. ERK1/2 signaling is essential for the chemoattraction exerted by human FGF2 and human anosmin-1 on newborn rat and mouse OPCs via FGFR1. Glia. 2014;62:374-86 pubmed 出版商
  445. Xu C, Chen H, Wang X, Gao J, Che Y, Li Y, et al. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling. J Biol Chem. 2014;289:827-37 pubmed 出版商
  446. Wang J, Chen J, Miller D, Li W. Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma. Mol Cancer Ther. 2014;13:16-26 pubmed 出版商
  447. Castorina A, Scuderi S, D Amico A, Drago F, D Agata V. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways. Exp Cell Res. 2014;322:108-21 pubmed 出版商
  448. Udagawa T, Farny N, Jakovcevski M, Kaphzan H, Alarcon J, Anilkumar S, et al. Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat Med. 2013;19:1473-7 pubmed 出版商
  449. Lu J, Chang Y, Wang C, Lin Y, Lin C, Wu Z. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor ?-induced lipolysis in 3T3-L1 adipocytes. PLoS ONE. 2013;8:e71517 pubmed 出版商
  450. O Brien M, Carbin S, Morrison J, Smith T. Decreased myometrial p160 ROCK-1 expression in obese women at term pregnancy. Reprod Biol Endocrinol. 2013;11:79 pubmed 出版商
  451. Kucherlapati M, Esfahani S, Habibollahi P, Wang J, Still E, Bronson R, et al. Genotype directed therapy in murine mismatch repair deficient tumors. PLoS ONE. 2013;8:e68817 pubmed 出版商
  452. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed 出版商
  453. Li Y, Takahashi M, Stork P. Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation. J Biol Chem. 2013;288:27646-57 pubmed 出版商
  454. Mao X, Hütt Cabezas M, Orr B, Weingart M, Taylor I, Rajan A, et al. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget. 2013;4:1050-64 pubmed
  455. Beckham T, Cheng J, Lu P, Shao Y, Troyer D, Lance R, et al. Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling. Oncogenesis. 2013;2:e49 pubmed 出版商
  456. Henderson Y, Toro Serra R, Chen Y, Ryu J, Frederick M, Zhou G, et al. Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck. 2014;36:375-84 pubmed 出版商
  457. Ahnstedt H, Cao L, Krause D, Warfvinge K, Saveland H, Nilsson O, et al. Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries. PLoS ONE. 2013;8:e62698 pubmed 出版商
  458. Lin S, Hoffmann K, Xiao Z, Jin N, Galli U, Mohr E, et al. MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma. Cancer Cell Int. 2013;13:3 pubmed 出版商
  459. Cieslik K, Trial J, Carlson S, Taffet G, Entman M. Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels. FASEB J. 2013;27:1761-71 pubmed 出版商
  460. Slowik A, Merres J, Elfgen A, Jansen S, Mohr F, Wruck C, et al. Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE)--and amyloid beta 1-42-induced signal transduction in glial cells. Mol Neurodegener. 2012;7:55 pubmed 出版商
  461. Brandenburg L, Jansen S, Albrecht L, Merres J, Gerber J, Pufe T, et al. CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide cathelicidin in glial cells. J Neuroimmunol. 2013;255:18-31 pubmed 出版商
  462. Kim J, Hwang I, Choi S, Lee H, Lee Y, Goo J, et al. Aqueous extract of Liriope platyphylla, a traditional Chinese medicine, significantly inhibits abdominal fat accumulation and improves glucose regulation in OLETF type II diabetes model rats. Lab Anim Res. 2012;28:181-91 pubmed 出版商
  463. Turco M, Furia L, Dietze A, Fernandez Diaz L, Ronzoni S, Sciullo A, et al. Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the ShcD/RaLP adaptor protein. Stem Cells. 2012;30:2423-36 pubmed 出版商
  464. Jarosz M, Robbez Masson L, Chioni A, Cross B, Rosewell I, Grose R. Fibroblast growth factor 22 is not essential for skin development and repair but plays a role in tumorigenesis. PLoS ONE. 2012;7:e39436 pubmed 出版商
  465. Iio W, Matsukawa N, Tsukahara T, Toyoda A. The effects of oral taurine administration on behavior and hippocampal signal transduction in rats. Amino Acids. 2012;43:2037-46 pubmed 出版商
  466. Lemire B, Debigare R, Dubé A, Thériault M, Cote C, Maltais F. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol (1985). 2012;113:159-66 pubmed 出版商
  467. Machado Neto J, Favaro P, Lazarini M, Costa F, Olalla Saad S, Traina F. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. Biochim Biophys Acta. 2011;1813:1404-11 pubmed 出版商
  468. Urbanet R, Pilon C, Giorgino F, Vettor R, Fallo F. Insulin signaling in adipose tissue of patients with primary aldosteronism. J Endocrinol Invest. 2011;34:86-9 pubmed
  469. Chang J, Adams M, Clifton M, Liao M, Brooks J, Hasdemir B, et al. Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2. Am J Physiol Gastrointest Liver Physiol. 2011;300:G884-94 pubmed 出版商
  470. Modi H, Li L, Chu S, Rossi J, Yee J, Bhatia R. Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells. Leukemia. 2011;25:305-12 pubmed 出版商
  471. Kunath T, Saba El Leil M, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 2007;134:2895-902 pubmed
  472. Zha Y, Marks R, Ho A, Peterson A, Janardhan S, Brown I, et al. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol. 2006;7:1166-73 pubmed
  473. Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, et al. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res. 2006;72:152-62 pubmed
  474. Lo I, Shih J, Jiang M. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J Biomed Sci. 2005;12:377-88 pubmed
  475. Tsai M, Jiang M. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle. Life Sci. 2005;76:877-88 pubmed
  476. Usui S, Sugimoto N, Takuwa N, Sakagami S, Takata S, Kaneko S, et al. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Kruppel-like factor 5. J Biol Chem. 2004;279:12300-11 pubmed
  477. Hernandez M, Barrero M, Crespo M, Nieto M. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein. J Neurochem. 2000;75:1575-82 pubmed
  478. Chan E, Stang S, Bottorff D, Stone J. Hypothermic stress leads to activation of Ras-Erk signaling. J Clin Invest. 1999;103:1337-44 pubmed
  479. Korneyev A. Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity. Neurochem Res. 1998;23:1539-43 pubmed
  480. Webb C, Van Aelst L, Wigler M, Vande Woude G. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A. 1998;95:8773-8 pubmed
  481. Duesbery N, Webb C, Leppla S, Gordon V, Klimpel K, Copeland T, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 1998;280:734-7 pubmed
  482. Hidari K, Weyrich A, Zimmerman G, McEver R. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J Biol Chem. 1997;272:28750-6 pubmed